Master Alliance Provisions Guide (MAPGuide)

Search Results For:

  • Agreement Type:
    • R&D Collaboration Agreement
(Click + to show provisions)
Agreement title
Effective date
Partner type
Technology
Development stage
Alnylam Pharmaceuticals - University of British Columbia- AlCana Technology, Sponsored Research Agreement
2009
Academic institution
Industry
Drug
Vaccine
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
PATH - Aridis, Rotavirus Vaccine Development Agreement
2007
Industry
Product development partnership
Vaccine
Early clinical (through Phase 2)
AUTM Model Inter-Institutional Research Collaboration Agreement
2015
Academic institution
Device
Diagnostic
Drug
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Sanofi - Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
2020
Industry
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
2021
Industry
Vaccine
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
DNDi Template Development Collaboration and License Agreement
2023
Academic institution
Industry
Non-profit research organization
Product development partnership
Drug
Early clinical (through Phase 2)
Late clinical (Phase 3)
DNDi Template Research Collaboration and License Agreement
2023
Academic institution
Industry
Non-profit research organization
Product development partnership
Drug
Discovery/Concept
Preclinical
DNDi - BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
2009
Industry
Product development partnership
Drug
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
WHO - Manufacturer, Ebola Products Collaboration LOA Template
2015
Academic institution
Industry
Multilateral organization
Non-profit research organization
Product development partnership
Drug
Vaccine
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
DNDi/GARDP - Entasis, Gonorrhoea Medication, Collaboration Agreement
2017
Industry
Product development partnership
Drug
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
2009
Industry
Product development partnership
Diagnostic
Drug
Vaccine
Discovery/Concept
IMI 2 JU Model Consortium Agreement
2017
Academic institution
Industry
Non-profit research organization
Product development partnership
Device
Diagnostic
Drug
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Lambert Toolkit, Consortium Agreement D Template
2019
Academic institution
Industry
Device
Diagnostic
Drug
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
2014
Industry
Vaccine
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Public Health England, Model Fast Track Testing & Evaluation Agreement
2014
Academic institution
Government
Industry
Non-profit research organization
Product development partnership
Diagnostic
Drug
Vaccine
Discovery/Concept
Preclinical
Academic Institution - Company, Research Collaboration Agreement
2016
Academic institution
Industry
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing
Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
2011
Funder
Industry
Non-profit research organization
Drug
Late clinical (Phase 3)
Commercialization
Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
2006
Industry
Non-profit research organization
Drug
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
2005
Government
Industry
Drug
Late clinical (Phase 3)
WHO Template Collaboration Agreement
2015
Academic institution
Industry
Multilateral organization
Non-profit research organization
Product development partnership
Device
Diagnostic
Drug
Vaccine
Discovery/Concept
Preclinical
Early clinical (through Phase 2)
Late clinical (Phase 3)
Commercialization
Field Testing

				GHIAA2019\MapguideSearch Object
(
    [search_parameters] => Array
        (
            [agreement-type] => Array
                (
                    [0] => rd-collaboration-agreement
                )

        )

    [filters] => Array
        (
            [agreement] => Array
                (
                    [agreement-type] => Array
                        (
                            [0] => rd-collaboration-agreement
                        )

                )

        )

    [child_filters] => Array
        (
        )

    [agreement_args] => Array
        (
            [post_type] => agreement
            [posts_per_page] => -1
            [tax_query] => Array
                (
                    [0] => Array
                        (
                            [taxonomy] => agreement-type
                            [field] => slug
                            [terms] => Array
                                (
                                    [0] => rd-collaboration-agreement
                                )

                        )

                )

        )

    [provision_args] => Array
        (
            [post_type] => provision_document
            [posts_per_page] => -1
            [tax_query] => Array
                (
                )

            [meta_query] => Array
                (
                    [relation] => OR
                    [0] => Array
                        (
                            [key] => agreement
                            [value] => "1100"
                            [compare] => LIKE
                        )

                    [1] => Array
                        (
                            [key] => agreement
                            [value] => "5679"
                            [compare] => LIKE
                        )

                    [2] => Array
                        (
                            [key] => agreement
                            [value] => "1037"
                            [compare] => LIKE
                        )

                    [3] => Array
                        (
                            [key] => agreement
                            [value] => "3817"
                            [compare] => LIKE
                        )

                    [4] => Array
                        (
                            [key] => agreement
                            [value] => "6290"
                            [compare] => LIKE
                        )

                    [5] => Array
                        (
                            [key] => agreement
                            [value] => "9858"
                            [compare] => LIKE
                        )

                    [6] => Array
                        (
                            [key] => agreement
                            [value] => "9849"
                            [compare] => LIKE
                        )

                    [7] => Array
                        (
                            [key] => agreement
                            [value] => "4871"
                            [compare] => LIKE
                        )

                    [8] => Array
                        (
                            [key] => agreement
                            [value] => "12483"
                            [compare] => LIKE
                        )

                    [9] => Array
                        (
                            [key] => agreement
                            [value] => "1076"
                            [compare] => LIKE
                        )

                    [10] => Array
                        (
                            [key] => agreement
                            [value] => "1078"
                            [compare] => LIKE
                        )

                    [11] => Array
                        (
                            [key] => agreement
                            [value] => "1103"
                            [compare] => LIKE
                        )

                    [12] => Array
                        (
                            [key] => agreement
                            [value] => "1104"
                            [compare] => LIKE
                        )

                    [13] => Array
                        (
                            [key] => agreement
                            [value] => "12444"
                            [compare] => LIKE
                        )

                    [14] => Array
                        (
                            [key] => agreement
                            [value] => "12422"
                            [compare] => LIKE
                        )

                    [15] => Array
                        (
                            [key] => agreement
                            [value] => "2420"
                            [compare] => LIKE
                        )

                    [16] => Array
                        (
                            [key] => agreement
                            [value] => "12108"
                            [compare] => LIKE
                        )

                    [17] => Array
                        (
                            [key] => agreement
                            [value] => "11568"
                            [compare] => LIKE
                        )

                    [18] => Array
                        (
                            [key] => agreement
                            [value] => "1098"
                            [compare] => LIKE
                        )

                    [19] => Array
                        (
                            [key] => agreement
                            [value] => "1096"
                            [compare] => LIKE
                        )

                )

        )

    [text_agreement_args] => 
    [text_provision_args] => 
    [agreement_ids] => Array
        (
            [0] => 1100
            [1] => 5679
            [2] => 1037
            [3] => 3817
            [4] => 6290
            [5] => 9858
            [6] => 9849
            [7] => 4871
            [8] => 12483
            [9] => 1076
            [10] => 1078
            [11] => 1103
            [12] => 1104
            [13] => 12444
            [14] => 12422
            [15] => 2420
            [16] => 12108
            [17] => 11568
            [18] => 1098
            [19] => 1096
        )

    [agreement_q_rslts] => WP_Query Object
        (
            [query] => Array
                (
                    [post_type] => agreement
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => rd-collaboration-agreement
                                        )

                                )

                        )

                )

            [query_vars] => Array
                (
                    [post_type] => agreement
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => rd-collaboration-agreement
                                        )

                                )

                        )

                    [error] => 
                    [m] => 
                    [p] => 0
                    [post_parent] => 
                    [subpost] => 
                    [subpost_id] => 
                    [attachment] => 
                    [attachment_id] => 0
                    [name] => 
                    [pagename] => 
                    [page_id] => 0
                    [second] => 
                    [minute] => 
                    [hour] => 
                    [day] => 0
                    [monthnum] => 0
                    [year] => 0
                    [w] => 0
                    [category_name] => 
                    [tag] => 
                    [cat] => 
                    [tag_id] => 
                    [author] => 
                    [author_name] => 
                    [feed] => 
                    [tb] => 
                    [paged] => 0
                    [meta_key] => 
                    [meta_value] => 
                    [preview] => 
                    [s] => 
                    [sentence] => 
                    [title] => 
                    [fields] => 
                    [menu_order] => 
                    [embed] => 
                    [category__in] => Array
                        (
                        )

                    [category__not_in] => Array
                        (
                        )

                    [category__and] => Array
                        (
                        )

                    [post__in] => Array
                        (
                        )

                    [post__not_in] => Array
                        (
                        )

                    [post_name__in] => Array
                        (
                        )

                    [tag__in] => Array
                        (
                        )

                    [tag__not_in] => Array
                        (
                        )

                    [tag__and] => Array
                        (
                        )

                    [tag_slug__in] => Array
                        (
                        )

                    [tag_slug__and] => Array
                        (
                        )

                    [post_parent__in] => Array
                        (
                        )

                    [post_parent__not_in] => Array
                        (
                        )

                    [author__in] => Array
                        (
                        )

                    [author__not_in] => Array
                        (
                        )

                    [search_columns] => Array
                        (
                        )

                    [orderby] => title
                    [order] => ASC
                    [ignore_sticky_posts] => 
                    [suppress_filters] => 
                    [cache_results] => 1
                    [update_post_term_cache] => 1
                    [update_menu_item_cache] => 
                    [lazy_load_term_meta] => 1
                    [update_post_meta_cache] => 1
                    [nopaging] => 1
                    [comments_per_page] => 50
                    [no_found_rows] => 
                    [taxonomy] => agreement-type
                    [term] => rd-collaboration-agreement
                )

            [tax_query] => WP_Tax_Query Object
                (
                    [queries] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [terms] => Array
                                        (
                                            [0] => rd-collaboration-agreement
                                        )

                                    [field] => slug
                                    [operator] => IN
                                    [include_children] => 1
                                )

                        )

                    [relation] => AND
                    [table_aliases:protected] => Array
                        (
                            [0] => wpry_term_relationships
                        )

                    [queried_terms] => Array
                        (
                            [agreement-type] => Array
                                (
                                    [terms] => Array
                                        (
                                            [0] => rd-collaboration-agreement
                                        )

                                    [field] => slug
                                )

                        )

                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                )

            [meta_query] => WP_Meta_Query Object
                (
                    [queries] => Array
                        (
                        )

                    [relation] => 
                    [meta_table] => 
                    [meta_id_column] => 
                    [primary_table] => 
                    [primary_id_column] => 
                    [table_aliases:protected] => Array
                        (
                        )

                    [clauses:protected] => Array
                        (
                        )

                    [has_or_relation:protected] => 
                )

            [date_query] => 
            [request] => SELECT   wpry_posts.*
					 FROM wpry_posts  LEFT JOIN wpry_term_relationships ON (wpry_posts.ID = wpry_term_relationships.object_id)
					 WHERE 1=1  AND ( 
  wpry_term_relationships.term_taxonomy_id IN (332)
) AND ((wpry_posts.post_type = 'agreement' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
					 GROUP BY wpry_posts.ID
					 ORDER BY wpry_posts.post_title ASC
					 
            [posts] => Array
                (
                    [0] => WP_Post Object
                        (
                            [ID] => 1100
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:40:26
                            [post_date_gmt] => 2020-05-21 20:40:26
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:14:15
                            [post_modified_gmt] => 2022-10-11 12:14:15
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1100
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [1] => WP_Post Object
                        (
                            [ID] => 5679
                            [post_author] => 5
                            [post_date] => 2022-09-06 11:39:59
                            [post_date_gmt] => 2022-09-06 11:39:59
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals - University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:15:21
                            [post_modified_gmt] => 2022-10-11 12:15:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=5679
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [2] => WP_Post Object
                        (
                            [ID] => 1037
                            [post_author] => 6
                            [post_date] => 2020-05-20 21:04:09
                            [post_date_gmt] => 2020-05-20 21:04:09
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-inter-institutional-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:15:43
                            [post_modified_gmt] => 2022-10-11 12:15:43
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1037
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [3] => WP_Post Object
                        (
                            [ID] => 3817
                            [post_author] => 6
                            [post_date] => 2021-09-15 10:46:18
                            [post_date_gmt] => 2021-09-15 10:46:18
                            [post_content] => 
                            [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-and-gsk-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:16:37
                            [post_modified_gmt] => 2022-10-11 12:16:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3817
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [4] => WP_Post Object
                        (
                            [ID] => 6290
                            [post_author] => 5
                            [post_date] => 2022-10-26 08:36:42
                            [post_date_gmt] => 2022-10-26 08:36:42
                            [post_content] => 
                            [post_title] => DNDi - BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-04-19 10:44:05
                            [post_modified_gmt] => 2023-04-19 10:44:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=6290
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [5] => WP_Post Object
                        (
                            [ID] => 9858
                            [post_author] => 5
                            [post_date] => 2023-04-14 11:42:47
                            [post_date_gmt] => 2023-04-14 11:42:47
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:23:08
                            [post_modified_gmt] => 2024-07-16 14:23:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=9858
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [6] => WP_Post Object
                        (
                            [ID] => 9849
                            [post_author] => 5
                            [post_date] => 2023-04-14 11:41:02
                            [post_date_gmt] => 2023-04-14 11:41:02
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:23:24
                            [post_modified_gmt] => 2024-07-16 14:23:24
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=9849
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [7] => WP_Post Object
                        (
                            [ID] => 4871
                            [post_author] => 5
                            [post_date] => 2022-06-07 11:12:12
                            [post_date_gmt] => 2022-06-07 11:12:12
                            [post_content] => 
                            [post_title] => DNDi/GARDP - Entasis, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhea-medication-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-04-19 10:44:58
                            [post_modified_gmt] => 2023-04-19 10:44:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4871
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [8] => WP_Post Object
                        (
                            [ID] => 12483
                            [post_author] => 5
                            [post_date] => 2025-01-14 14:31:53
                            [post_date_gmt] => 2025-01-14 14:31:53
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-14 14:31:53
                            [post_modified_gmt] => 2025-01-14 14:31:53
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12483
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [9] => WP_Post Object
                        (
                            [ID] => 1076
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:14:10
                            [post_date_gmt] => 2020-05-21 20:14:10
                            [post_content] => 
                            [post_title] => IMI 2 JU Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2-ju-model-consortium-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-07 11:54:03
                            [post_modified_gmt] => 2024-11-07 11:54:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1076
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [10] => WP_Post Object
                        (
                            [ID] => 1078
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:16:03
                            [post_date_gmt] => 2020-05-21 20:16:03
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:18:40
                            [post_modified_gmt] => 2022-10-11 12:18:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1078
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [11] => WP_Post Object
                        (
                            [ID] => 1103
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:41:55
                            [post_date_gmt] => 2020-05-21 20:41:55
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => merck-bsc-license-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:18:56
                            [post_modified_gmt] => 2022-10-11 12:18:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1103
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [12] => WP_Post Object
                        (
                            [ID] => 1104
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:42:29
                            [post_date_gmt] => 2020-05-21 20:42:29
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:21:19
                            [post_modified_gmt] => 2022-10-11 12:21:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1104
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [13] => WP_Post Object
                        (
                            [ID] => 12444
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:29:57
                            [post_date_gmt] => 2024-12-17 12:29:57
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 14:37:04
                            [post_modified_gmt] => 2024-12-17 14:37:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12444
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [14] => WP_Post Object
                        (
                            [ID] => 12422
                            [post_author] => 5
                            [post_date] => 2024-12-10 10:35:56
                            [post_date_gmt] => 2024-12-10 10:35:56
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 10:35:56
                            [post_modified_gmt] => 2024-12-10 10:35:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12422
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [15] => WP_Post Object
                        (
                            [ID] => 2420
                            [post_author] => 5
                            [post_date] => 2020-12-14 14:59:07
                            [post_date_gmt] => 2020-12-14 14:59:07
                            [post_content] => 
                            [post_title] => Sanofi - Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => collaboration-and-license-agreement-between-sanofi-pasteur-inc-sanofi-and-translate-bio-ma-inc-translate-bio-or-tb-and-first-amendment-co
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:21:49
                            [post_modified_gmt] => 2022-10-11 12:21:49
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=2420
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [16] => WP_Post Object
                        (
                            [ID] => 12108
                            [post_author] => 5
                            [post_date] => 2024-11-22 12:46:28
                            [post_date_gmt] => 2024-11-22 12:46:28
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 15:59:57
                            [post_modified_gmt] => 2024-12-02 15:59:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12108
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [17] => WP_Post Object
                        (
                            [ID] => 11568
                            [post_author] => 5
                            [post_date] => 2023-12-20 08:15:11
                            [post_date_gmt] => 2023-12-20 08:15:11
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 08:15:11
                            [post_modified_gmt] => 2023-12-20 08:15:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11568
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [18] => WP_Post Object
                        (
                            [ID] => 1098
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:38:25
                            [post_date_gmt] => 2020-05-21 20:38:25
                            [post_content] => 
                            [post_title] => WHO - Manufacturer, Ebola Products Collaboration LOA Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ebola-who-manufacturer-loa-annex
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-06 12:07:11
                            [post_modified_gmt] => 2024-11-06 12:07:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1098
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [19] => WP_Post Object
                        (
                            [ID] => 1096
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:36:30
                            [post_date_gmt] => 2020-05-21 20:36:30
                            [post_content] => 
                            [post_title] => WHO Template Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => who-template-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-30 14:11:04
                            [post_modified_gmt] => 2024-10-30 14:11:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1096
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                )

            [post_count] => 20
            [current_post] => -1
            [before_loop] => 1
            [in_the_loop] => 
            [post] => WP_Post Object
                (
                    [ID] => 1100
                    [post_author] => 6
                    [post_date] => 2020-05-21 20:40:26
                    [post_date_gmt] => 2020-05-21 20:40:26
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-10-11 12:14:15
                    [post_modified_gmt] => 2022-10-11 12:14:15
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1100
                    [menu_order] => 0
                    [post_type] => agreement
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [comment_count] => 0
            [current_comment] => -1
            [found_posts] => 20
            [max_num_pages] => 0
            [max_num_comment_pages] => 0
            [is_single] => 
            [is_preview] => 
            [is_page] => 
            [is_archive] => 1
            [is_date] => 
            [is_year] => 
            [is_month] => 
            [is_day] => 
            [is_time] => 
            [is_author] => 
            [is_category] => 
            [is_tag] => 
            [is_tax] => 1
            [is_search] => 
            [is_feed] => 
            [is_comment_feed] => 
            [is_trackback] => 
            [is_home] => 
            [is_privacy_policy] => 
            [is_404] => 
            [is_embed] => 
            [is_paged] => 
            [is_admin] => 
            [is_attachment] => 
            [is_singular] => 
            [is_robots] => 
            [is_favicon] => 
            [is_posts_page] => 
            [is_post_type_archive] => 1
            [query_vars_hash:WP_Query:private] => 0e75ae95fb615b3d099fa297d61354aa
            [query_vars_changed:WP_Query:private] => 1
            [thumbnails_cached] => 
            [allow_query_attachment_by_filename:protected] => 
            [stopwords:WP_Query:private] => 
            [compat_fields:WP_Query:private] => Array
                (
                    [0] => query_vars_hash
                    [1] => query_vars_changed
                )

            [compat_methods:WP_Query:private] => Array
                (
                    [0] => init_query_flags
                    [1] => parse_tax_query
                )

        )

    [provision_q_rslts] => WP_Query Object
        (
            [query] => Array
                (
                    [post_type] => provision_document
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                        )

                    [meta_query] => Array
                        (
                            [relation] => OR
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1100"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "5679"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "1037"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "6290"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4871"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "12483"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "1076"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "1078"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "1104"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "12444"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "12422"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "1098"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "1096"
                                    [compare] => LIKE
                                )

                        )

                )

            [query_vars] => Array
                (
                    [post_type] => provision_document
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                        )

                    [meta_query] => Array
                        (
                            [relation] => OR
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1100"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "5679"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "1037"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "6290"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4871"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "12483"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "1076"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "1078"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "1104"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "12444"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "12422"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "1098"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "1096"
                                    [compare] => LIKE
                                )

                        )

                    [error] => 
                    [m] => 
                    [p] => 0
                    [post_parent] => 
                    [subpost] => 
                    [subpost_id] => 
                    [attachment] => 
                    [attachment_id] => 0
                    [name] => 
                    [pagename] => 
                    [page_id] => 0
                    [second] => 
                    [minute] => 
                    [hour] => 
                    [day] => 0
                    [monthnum] => 0
                    [year] => 0
                    [w] => 0
                    [category_name] => 
                    [tag] => 
                    [cat] => 
                    [tag_id] => 
                    [author] => 
                    [author_name] => 
                    [feed] => 
                    [tb] => 
                    [paged] => 0
                    [meta_key] => 
                    [meta_value] => 
                    [preview] => 
                    [s] => 
                    [sentence] => 
                    [title] => 
                    [fields] => 
                    [menu_order] => 
                    [embed] => 
                    [category__in] => Array
                        (
                        )

                    [category__not_in] => Array
                        (
                        )

                    [category__and] => Array
                        (
                        )

                    [post__in] => Array
                        (
                        )

                    [post__not_in] => Array
                        (
                        )

                    [post_name__in] => Array
                        (
                        )

                    [tag__in] => Array
                        (
                        )

                    [tag__not_in] => Array
                        (
                        )

                    [tag__and] => Array
                        (
                        )

                    [tag_slug__in] => Array
                        (
                        )

                    [tag_slug__and] => Array
                        (
                        )

                    [post_parent__in] => Array
                        (
                        )

                    [post_parent__not_in] => Array
                        (
                        )

                    [author__in] => Array
                        (
                        )

                    [author__not_in] => Array
                        (
                        )

                    [search_columns] => Array
                        (
                        )

                    [ignore_sticky_posts] => 
                    [suppress_filters] => 
                    [cache_results] => 1
                    [update_post_term_cache] => 1
                    [update_menu_item_cache] => 
                    [lazy_load_term_meta] => 1
                    [update_post_meta_cache] => 1
                    [nopaging] => 1
                    [comments_per_page] => 50
                    [no_found_rows] => 
                    [order] => DESC
                )

            [tax_query] => WP_Tax_Query Object
                (
                    [queries] => Array
                        (
                        )

                    [relation] => AND
                    [table_aliases:protected] => Array
                        (
                        )

                    [queried_terms] => Array
                        (
                        )

                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                )

            [meta_query] => WP_Meta_Query Object
                (
                    [queries] => Array
                        (
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1100"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "5679"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "1037"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "6290"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4871"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "12483"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "1076"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "1078"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "1104"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "12444"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "12422"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "1098"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "1096"
                                    [compare] => LIKE
                                )

                            [relation] => OR
                        )

                    [relation] => OR
                    [meta_table] => wpry_postmeta
                    [meta_id_column] => post_id
                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                    [table_aliases:protected] => Array
                        (
                            [0] => wpry_postmeta
                        )

                    [clauses:protected] => Array
                        (
                            [wpry_postmeta] => Array
                                (
                                    [key] => agreement
                                    [value] => "1100"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-1] => Array
                                (
                                    [key] => agreement
                                    [value] => "5679"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-2] => Array
                                (
                                    [key] => agreement
                                    [value] => "1037"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-3] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-4] => Array
                                (
                                    [key] => agreement
                                    [value] => "6290"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-5] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-6] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4871"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-8] => Array
                                (
                                    [key] => agreement
                                    [value] => "12483"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-9] => Array
                                (
                                    [key] => agreement
                                    [value] => "1076"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-10] => Array
                                (
                                    [key] => agreement
                                    [value] => "1078"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-11] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-12] => Array
                                (
                                    [key] => agreement
                                    [value] => "1104"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-13] => Array
                                (
                                    [key] => agreement
                                    [value] => "12444"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-14] => Array
                                (
                                    [key] => agreement
                                    [value] => "12422"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-15] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-16] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-17] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-18] => Array
                                (
                                    [key] => agreement
                                    [value] => "1098"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-19] => Array
                                (
                                    [key] => agreement
                                    [value] => "1096"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                        )

                    [has_or_relation:protected] => 1
                )

            [date_query] => 
            [request] => SELECT   wpry_posts.*
					 FROM wpry_posts  INNER JOIN wpry_postmeta ON ( wpry_posts.ID = wpry_postmeta.post_id )
					 WHERE 1=1  AND ( 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1100\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"5679\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1037\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"3817\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"6290\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"9858\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"9849\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"4871\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"12483\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1076\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1078\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1103\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1104\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"12444\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"12422\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"2420\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"12108\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"11568\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1098\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}\"1096\"{85ff11cabee2f38c8f4f5548f1f6ee2b3480a3fddc8cbfc7ecded63d28c2adef}' )
) AND ((wpry_posts.post_type = 'provision_document' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
					 GROUP BY wpry_posts.ID
					 ORDER BY wpry_posts.post_date DESC
					 
            [posts] => Array
                (
                    [0] => WP_Post Object
                        (
                            [ID] => 12500
                            [post_author] => 5
                            [post_date] => 2025-01-09 15:35:20
                            [post_date_gmt] => 2025-01-09 15:35:20
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 15:35:20
                            [post_modified_gmt] => 2025-01-09 15:35:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12500
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [1] => WP_Post Object
                        (
                            [ID] => 12499
                            [post_author] => 5
                            [post_date] => 2025-01-09 15:31:52
                            [post_date_gmt] => 2025-01-09 15:31:52
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 16:08:52
                            [post_modified_gmt] => 2025-01-09 16:08:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12499
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [2] => WP_Post Object
                        (
                            [ID] => 12498
                            [post_author] => 5
                            [post_date] => 2025-01-09 15:12:41
                            [post_date_gmt] => 2025-01-09 15:12:41
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 15:32:14
                            [post_modified_gmt] => 2025-01-09 15:32:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12498
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [3] => WP_Post Object
                        (
                            [ID] => 12497
                            [post_author] => 5
                            [post_date] => 2025-01-09 15:09:11
                            [post_date_gmt] => 2025-01-09 15:09:11
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-14 15:02:50
                            [post_modified_gmt] => 2025-01-14 15:02:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12497
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [4] => WP_Post Object
                        (
                            [ID] => 12496
                            [post_author] => 5
                            [post_date] => 2025-01-09 15:03:22
                            [post_date_gmt] => 2025-01-09 15:03:22
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 15:03:22
                            [post_modified_gmt] => 2025-01-09 15:03:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12496
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [5] => WP_Post Object
                        (
                            [ID] => 12495
                            [post_author] => 5
                            [post_date] => 2025-01-09 12:04:44
                            [post_date_gmt] => 2025-01-09 12:04:44
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-14 14:00:29
                            [post_modified_gmt] => 2025-01-14 14:00:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12495
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [6] => WP_Post Object
                        (
                            [ID] => 12494
                            [post_author] => 5
                            [post_date] => 2025-01-09 11:31:20
                            [post_date_gmt] => 2025-01-09 11:31:20
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-14 14:43:26
                            [post_modified_gmt] => 2025-01-14 14:43:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12494
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [7] => WP_Post Object
                        (
                            [ID] => 12493
                            [post_author] => 5
                            [post_date] => 2025-01-09 11:05:04
                            [post_date_gmt] => 2025-01-09 11:05:04
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 11:05:04
                            [post_modified_gmt] => 2025-01-09 11:05:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12493
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [8] => WP_Post Object
                        (
                            [ID] => 12492
                            [post_author] => 5
                            [post_date] => 2025-01-09 09:40:33
                            [post_date_gmt] => 2025-01-09 09:40:33
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-10 11:06:22
                            [post_modified_gmt] => 2025-01-10 11:06:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12492
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [9] => WP_Post Object
                        (
                            [ID] => 12491
                            [post_author] => 5
                            [post_date] => 2025-01-09 09:29:05
                            [post_date_gmt] => 2025-01-09 09:29:05
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-14 14:44:45
                            [post_modified_gmt] => 2025-01-14 14:44:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12491
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [10] => WP_Post Object
                        (
                            [ID] => 12490
                            [post_author] => 5
                            [post_date] => 2025-01-09 09:24:22
                            [post_date_gmt] => 2025-01-09 09:24:22
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 09:24:22
                            [post_modified_gmt] => 2025-01-09 09:24:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12490
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [11] => WP_Post Object
                        (
                            [ID] => 12488
                            [post_author] => 5
                            [post_date] => 2025-01-09 08:50:08
                            [post_date_gmt] => 2025-01-09 08:50:08
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 08:50:08
                            [post_modified_gmt] => 2025-01-09 08:50:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12488
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [12] => WP_Post Object
                        (
                            [ID] => 12486
                            [post_author] => 5
                            [post_date] => 2025-01-09 08:50:03
                            [post_date_gmt] => 2025-01-09 08:50:03
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 08:50:03
                            [post_modified_gmt] => 2025-01-09 08:50:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12486
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [13] => WP_Post Object
                        (
                            [ID] => 12489
                            [post_author] => 5
                            [post_date] => 2025-01-09 08:49:47
                            [post_date_gmt] => 2025-01-09 08:49:47
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 08:49:47
                            [post_modified_gmt] => 2025-01-09 08:49:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12489
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [14] => WP_Post Object
                        (
                            [ID] => 12485
                            [post_author] => 5
                            [post_date] => 2025-01-08 15:46:44
                            [post_date_gmt] => 2025-01-08 15:46:44
                            [post_content] => 
                            [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-09 08:49:58
                            [post_modified_gmt] => 2025-01-09 08:49:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12485
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [15] => WP_Post Object
                        (
                            [ID] => 12461
                            [post_author] => 5
                            [post_date] => 2024-12-17 14:50:55
                            [post_date_gmt] => 2024-12-17 14:50:55
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 14:59:52
                            [post_modified_gmt] => 2024-12-17 14:59:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12461
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [16] => WP_Post Object
                        (
                            [ID] => 12460
                            [post_author] => 5
                            [post_date] => 2024-12-17 14:23:56
                            [post_date_gmt] => 2024-12-17 14:23:56
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:00:07
                            [post_modified_gmt] => 2024-12-17 15:00:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12460
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [17] => WP_Post Object
                        (
                            [ID] => 12459
                            [post_author] => 5
                            [post_date] => 2024-12-17 13:51:05
                            [post_date_gmt] => 2024-12-17 13:51:05
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:00:21
                            [post_modified_gmt] => 2024-12-17 15:00:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12459
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [18] => WP_Post Object
                        (
                            [ID] => 12458
                            [post_author] => 5
                            [post_date] => 2024-12-17 13:36:17
                            [post_date_gmt] => 2024-12-17 13:36:17
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:00:32
                            [post_modified_gmt] => 2024-12-17 15:00:32
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12458
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [19] => WP_Post Object
                        (
                            [ID] => 12457
                            [post_author] => 5
                            [post_date] => 2024-12-17 13:25:38
                            [post_date_gmt] => 2024-12-17 13:25:38
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:00:46
                            [post_modified_gmt] => 2024-12-17 15:00:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12457
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [20] => WP_Post Object
                        (
                            [ID] => 12456
                            [post_author] => 5
                            [post_date] => 2024-12-17 13:14:52
                            [post_date_gmt] => 2024-12-17 13:14:52
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:00:59
                            [post_modified_gmt] => 2024-12-17 15:00:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12456
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [21] => WP_Post Object
                        (
                            [ID] => 12455
                            [post_author] => 5
                            [post_date] => 2024-12-17 13:07:14
                            [post_date_gmt] => 2024-12-17 13:07:14
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:01:12
                            [post_modified_gmt] => 2024-12-17 15:01:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12455
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [22] => WP_Post Object
                        (
                            [ID] => 12447
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:44:05
                            [post_date_gmt] => 2024-12-17 12:44:05
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:01:28
                            [post_modified_gmt] => 2024-12-17 15:01:28
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12447
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [23] => WP_Post Object
                        (
                            [ID] => 12449
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:42:52
                            [post_date_gmt] => 2024-12-17 12:42:52
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:01:44
                            [post_modified_gmt] => 2024-12-17 15:01:44
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12449
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [24] => WP_Post Object
                        (
                            [ID] => 12450
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:40:48
                            [post_date_gmt] => 2024-12-17 12:40:48
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 14:59:36
                            [post_modified_gmt] => 2024-12-17 14:59:36
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12450
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [25] => WP_Post Object
                        (
                            [ID] => 12448
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:39:24
                            [post_date_gmt] => 2024-12-17 12:39:24
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:01:57
                            [post_modified_gmt] => 2024-12-17 15:01:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12448
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [26] => WP_Post Object
                        (
                            [ID] => 12451
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:38:26
                            [post_date_gmt] => 2024-12-17 12:38:26
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:02:09
                            [post_modified_gmt] => 2024-12-17 15:02:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12451
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [27] => WP_Post Object
                        (
                            [ID] => 12452
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:36:37
                            [post_date_gmt] => 2024-12-17 12:36:37
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:02:22
                            [post_modified_gmt] => 2024-12-17 15:02:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12452
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [28] => WP_Post Object
                        (
                            [ID] => 12453
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:35:36
                            [post_date_gmt] => 2024-12-17 12:35:36
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:02:34
                            [post_modified_gmt] => 2024-12-17 15:02:34
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12453
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [29] => WP_Post Object
                        (
                            [ID] => 12454
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:34:26
                            [post_date_gmt] => 2024-12-17 12:34:26
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:02:46
                            [post_modified_gmt] => 2024-12-17 15:02:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12454
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [30] => WP_Post Object
                        (
                            [ID] => 12446
                            [post_author] => 5
                            [post_date] => 2024-12-17 12:29:26
                            [post_date_gmt] => 2024-12-17 12:29:26
                            [post_content] => 
                            [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-17 15:02:57
                            [post_modified_gmt] => 2024-12-17 15:02:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12446
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [31] => WP_Post Object
                        (
                            [ID] => 12443
                            [post_author] => 5
                            [post_date] => 2024-12-10 10:18:56
                            [post_date_gmt] => 2024-12-10 10:18:56
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-18
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 10:23:40
                            [post_modified_gmt] => 2024-12-10 10:23:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12443
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [32] => WP_Post Object
                        (
                            [ID] => 12442
                            [post_author] => 5
                            [post_date] => 2024-12-10 09:35:15
                            [post_date_gmt] => 2024-12-10 09:35:15
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:15:14
                            [post_modified_gmt] => 2024-12-10 13:15:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12442
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [33] => WP_Post Object
                        (
                            [ID] => 12440
                            [post_author] => 5
                            [post_date] => 2024-12-09 16:31:10
                            [post_date_gmt] => 2024-12-09 16:31:10
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:14:27
                            [post_modified_gmt] => 2024-12-10 13:14:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12440
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [34] => WP_Post Object
                        (
                            [ID] => 12439
                            [post_author] => 5
                            [post_date] => 2024-12-09 16:21:25
                            [post_date_gmt] => 2024-12-09 16:21:25
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-09 16:22:45
                            [post_modified_gmt] => 2024-12-09 16:22:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12439
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [35] => WP_Post Object
                        (
                            [ID] => 12438
                            [post_author] => 5
                            [post_date] => 2024-12-09 16:01:28
                            [post_date_gmt] => 2024-12-09 16:01:28
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:12:57
                            [post_modified_gmt] => 2024-12-10 13:12:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12438
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [36] => WP_Post Object
                        (
                            [ID] => 12437
                            [post_author] => 5
                            [post_date] => 2024-12-09 15:45:57
                            [post_date_gmt] => 2024-12-09 15:45:57
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:11:57
                            [post_modified_gmt] => 2024-12-10 13:11:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12437
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [37] => WP_Post Object
                        (
                            [ID] => 12435
                            [post_author] => 5
                            [post_date] => 2024-12-06 15:44:34
                            [post_date_gmt] => 2024-12-06 15:44:34
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 11:05:05
                            [post_modified_gmt] => 2024-12-10 11:05:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12435
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [38] => WP_Post Object
                        (
                            [ID] => 12434
                            [post_author] => 5
                            [post_date] => 2024-12-06 13:51:26
                            [post_date_gmt] => 2024-12-06 13:51:26
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 11:23:13
                            [post_modified_gmt] => 2024-12-10 11:23:13
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12434
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [39] => WP_Post Object
                        (
                            [ID] => 12433
                            [post_author] => 5
                            [post_date] => 2024-12-06 12:53:03
                            [post_date_gmt] => 2024-12-06 12:53:03
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-06 13:00:18
                            [post_modified_gmt] => 2024-12-06 13:00:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12433
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [40] => WP_Post Object
                        (
                            [ID] => 12432
                            [post_author] => 5
                            [post_date] => 2024-12-06 12:48:15
                            [post_date_gmt] => 2024-12-06 12:48:15
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:03:28
                            [post_modified_gmt] => 2024-12-10 13:03:28
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12432
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [41] => WP_Post Object
                        (
                            [ID] => 12431
                            [post_author] => 5
                            [post_date] => 2024-12-06 12:26:39
                            [post_date_gmt] => 2024-12-06 12:26:39
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 12:59:35
                            [post_modified_gmt] => 2024-12-10 12:59:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12431
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [42] => WP_Post Object
                        (
                            [ID] => 12430
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:59:58
                            [post_date_gmt] => 2024-12-06 11:59:58
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-06 11:59:58
                            [post_modified_gmt] => 2024-12-06 11:59:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12430
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [43] => WP_Post Object
                        (
                            [ID] => 12429
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:54:11
                            [post_date_gmt] => 2024-12-06 11:54:11
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 12:55:20
                            [post_modified_gmt] => 2024-12-10 12:55:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12429
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [44] => WP_Post Object
                        (
                            [ID] => 12428
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:53:23
                            [post_date_gmt] => 2024-12-06 11:53:23
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 10:44:05
                            [post_modified_gmt] => 2024-12-10 10:44:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12428
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [45] => WP_Post Object
                        (
                            [ID] => 12427
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:53:07
                            [post_date_gmt] => 2024-12-06 11:53:07
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 10:42:12
                            [post_modified_gmt] => 2024-12-10 10:42:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12427
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [46] => WP_Post Object
                        (
                            [ID] => 12426
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:52:52
                            [post_date_gmt] => 2024-12-06 11:52:52
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:10:45
                            [post_modified_gmt] => 2024-12-10 13:10:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12426
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [47] => WP_Post Object
                        (
                            [ID] => 12425
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:52:08
                            [post_date_gmt] => 2024-12-06 11:52:08
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:05:12
                            [post_modified_gmt] => 2024-12-10 13:05:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12425
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [48] => WP_Post Object
                        (
                            [ID] => 12424
                            [post_author] => 5
                            [post_date] => 2024-12-06 11:52:02
                            [post_date_gmt] => 2024-12-06 11:52:02
                            [post_content] => 
                            [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-10 13:06:33
                            [post_modified_gmt] => 2024-12-10 13:06:33
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12424
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [49] => WP_Post Object
                        (
                            [ID] => 12397
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:58:17
                            [post_date_gmt] => 2024-12-02 16:58:17
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:59:29
                            [post_modified_gmt] => 2024-12-02 16:59:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12397
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [50] => WP_Post Object
                        (
                            [ID] => 12110
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:57:40
                            [post_date_gmt] => 2024-12-02 16:57:40
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:57:40
                            [post_modified_gmt] => 2024-12-02 16:57:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12110
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [51] => WP_Post Object
                        (
                            [ID] => 12112
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:57:07
                            [post_date_gmt] => 2024-12-02 16:57:07
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:57:07
                            [post_modified_gmt] => 2024-12-02 16:57:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12112
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [52] => WP_Post Object
                        (
                            [ID] => 12111
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:56:26
                            [post_date_gmt] => 2024-12-02 16:56:26
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:56:26
                            [post_modified_gmt] => 2024-12-02 16:56:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12111
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [53] => WP_Post Object
                        (
                            [ID] => 12394
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:52:54
                            [post_date_gmt] => 2024-12-02 16:52:54
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:54:09
                            [post_modified_gmt] => 2024-12-02 16:54:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12394
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [54] => WP_Post Object
                        (
                            [ID] => 12398
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:51:33
                            [post_date_gmt] => 2024-12-02 16:51:33
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:51:33
                            [post_modified_gmt] => 2024-12-02 16:51:33
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12398
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [55] => WP_Post Object
                        (
                            [ID] => 12399
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:50:37
                            [post_date_gmt] => 2024-12-02 16:50:37
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:50:37
                            [post_modified_gmt] => 2024-12-02 16:50:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12399
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [56] => WP_Post Object
                        (
                            [ID] => 12400
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:50:09
                            [post_date_gmt] => 2024-12-02 16:50:09
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:50:09
                            [post_modified_gmt] => 2024-12-02 16:50:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12400
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [57] => WP_Post Object
                        (
                            [ID] => 12404
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:45:25
                            [post_date_gmt] => 2024-12-02 16:45:25
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:45:25
                            [post_modified_gmt] => 2024-12-02 16:45:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12404
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [58] => WP_Post Object
                        (
                            [ID] => 12396
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:33:33
                            [post_date_gmt] => 2024-12-02 16:33:33
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-06 16:04:07
                            [post_modified_gmt] => 2024-12-06 16:04:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12396
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [59] => WP_Post Object
                        (
                            [ID] => 12384
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:30:03
                            [post_date_gmt] => 2024-12-02 16:30:03
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:30:03
                            [post_modified_gmt] => 2024-12-02 16:30:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12384
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [60] => WP_Post Object
                        (
                            [ID] => 12114
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:26:14
                            [post_date_gmt] => 2024-12-02 16:26:14
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:26:14
                            [post_modified_gmt] => 2024-12-02 16:26:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12114
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [61] => WP_Post Object
                        (
                            [ID] => 12113
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:23:50
                            [post_date_gmt] => 2024-12-02 16:23:50
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:35:16
                            [post_modified_gmt] => 2024-12-02 16:35:16
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12113
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [62] => WP_Post Object
                        (
                            [ID] => 12395
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:15:41
                            [post_date_gmt] => 2024-12-02 16:15:41
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-06 15:28:17
                            [post_modified_gmt] => 2024-12-06 15:28:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12395
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [63] => WP_Post Object
                        (
                            [ID] => 12401
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:11:01
                            [post_date_gmt] => 2024-12-02 16:11:01
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:54:41
                            [post_modified_gmt] => 2024-12-02 16:54:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12401
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [64] => WP_Post Object
                        (
                            [ID] => 12393
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:07:52
                            [post_date_gmt] => 2024-12-02 16:07:52
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:34:17
                            [post_modified_gmt] => 2024-12-02 16:34:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12393
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [65] => WP_Post Object
                        (
                            [ID] => 12115
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:04:45
                            [post_date_gmt] => 2024-12-02 16:04:45
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 16:08:21
                            [post_modified_gmt] => 2024-12-02 16:08:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12115
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [66] => WP_Post Object
                        (
                            [ID] => 11584
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:43:47
                            [post_date_gmt] => 2023-12-21 12:43:47
                            [post_content] => 
                            [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-21 12:43:47
                            [post_modified_gmt] => 2023-12-21 12:43:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11584
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [67] => WP_Post Object
                        (
                            [ID] => 11583
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:34:00
                            [post_date_gmt] => 2023-12-21 12:34:00
                            [post_content] => 
                            [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-21 12:36:19
                            [post_modified_gmt] => 2023-12-21 12:36:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11583
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [68] => WP_Post Object
                        (
                            [ID] => 11582
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:31:08
                            [post_date_gmt] => 2023-12-21 12:31:08
                            [post_content] => 
                            [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 14:03:51
                            [post_modified_gmt] => 2023-12-23 14:03:51
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11582
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [69] => WP_Post Object
                        (
                            [ID] => 11578
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:25:49
                            [post_date_gmt] => 2023-12-21 12:25:49
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 13:41:06
                            [post_modified_gmt] => 2023-12-23 13:41:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11578
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [70] => WP_Post Object
                        (
                            [ID] => 11573
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:24:41
                            [post_date_gmt] => 2023-12-21 12:24:41
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 13:23:19
                            [post_modified_gmt] => 2023-12-23 13:23:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11573
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [71] => WP_Post Object
                        (
                            [ID] => 11577
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:24:14
                            [post_date_gmt] => 2023-12-21 12:24:14
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 13:44:52
                            [post_modified_gmt] => 2023-12-23 13:44:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11577
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [72] => WP_Post Object
                        (
                            [ID] => 11576
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:23:34
                            [post_date_gmt] => 2023-12-21 12:23:34
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 07:46:18
                            [post_modified_gmt] => 2024-09-04 07:46:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11576
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [73] => WP_Post Object
                        (
                            [ID] => 11575
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:22:39
                            [post_date_gmt] => 2023-12-21 12:22:39
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-21 12:22:39
                            [post_modified_gmt] => 2023-12-21 12:22:39
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11575
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [74] => WP_Post Object
                        (
                            [ID] => 11574
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:21:54
                            [post_date_gmt] => 2023-12-21 12:21:54
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 13:46:59
                            [post_modified_gmt] => 2023-12-23 13:46:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11574
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [75] => WP_Post Object
                        (
                            [ID] => 11572
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:21:17
                            [post_date_gmt] => 2023-12-21 12:21:17
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 13:59:48
                            [post_modified_gmt] => 2023-12-23 13:59:48
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11572
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [76] => WP_Post Object
                        (
                            [ID] => 11570
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:20:51
                            [post_date_gmt] => 2023-12-21 12:20:51
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 14:01:12
                            [post_modified_gmt] => 2023-12-23 14:01:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11570
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [77] => WP_Post Object
                        (
                            [ID] => 11581
                            [post_author] => 5
                            [post_date] => 2023-12-21 12:18:22
                            [post_date_gmt] => 2023-12-21 12:18:22
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-23 14:02:18
                            [post_modified_gmt] => 2023-12-23 14:02:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11581
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [78] => WP_Post Object
                        (
                            [ID] => 11580
                            [post_author] => 5
                            [post_date] => 2023-12-21 11:59:11
                            [post_date_gmt] => 2023-12-21 11:59:11
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 10:54:52
                            [post_modified_gmt] => 2024-09-04 10:54:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11580
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [79] => WP_Post Object
                        (
                            [ID] => 11579
                            [post_author] => 5
                            [post_date] => 2023-12-21 11:09:11
                            [post_date_gmt] => 2023-12-21 11:09:11
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-21 11:09:55
                            [post_modified_gmt] => 2023-12-21 11:09:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11579
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [80] => WP_Post Object
                        (
                            [ID] => 9894
                            [post_author] => 5
                            [post_date] => 2023-04-20 12:27:42
                            [post_date_gmt] => 2023-04-20 12:27:42
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-19
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-05 15:00:14
                            [post_modified_gmt] => 2023-06-05 15:00:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9894
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [81] => WP_Post Object
                        (
                            [ID] => 9893
                            [post_author] => 5
                            [post_date] => 2023-04-20 12:20:05
                            [post_date_gmt] => 2023-04-20 12:20:05
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-18
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 11:43:45
                            [post_modified_gmt] => 2023-06-27 11:43:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9893
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [82] => WP_Post Object
                        (
                            [ID] => 9892
                            [post_author] => 5
                            [post_date] => 2023-04-20 12:00:13
                            [post_date_gmt] => 2023-04-20 12:00:13
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 09:25:45
                            [post_modified_gmt] => 2024-01-11 09:25:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9892
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [83] => WP_Post Object
                        (
                            [ID] => 9891
                            [post_author] => 5
                            [post_date] => 2023-04-20 08:44:23
                            [post_date_gmt] => 2023-04-20 08:44:23
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:41:12
                            [post_modified_gmt] => 2023-06-27 13:41:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9891
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [84] => WP_Post Object
                        (
                            [ID] => 9890
                            [post_author] => 5
                            [post_date] => 2023-04-20 08:28:58
                            [post_date_gmt] => 2023-04-20 08:28:58
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:39:29
                            [post_modified_gmt] => 2023-06-27 13:39:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9890
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [85] => WP_Post Object
                        (
                            [ID] => 9889
                            [post_author] => 5
                            [post_date] => 2023-04-20 08:26:21
                            [post_date_gmt] => 2023-04-20 08:26:21
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:27:42
                            [post_modified_gmt] => 2023-06-27 13:27:42
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9889
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [86] => WP_Post Object
                        (
                            [ID] => 9888
                            [post_author] => 5
                            [post_date] => 2023-04-20 08:15:26
                            [post_date_gmt] => 2023-04-20 08:15:26
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:20:51
                            [post_modified_gmt] => 2023-06-27 13:20:51
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9888
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [87] => WP_Post Object
                        (
                            [ID] => 9886
                            [post_author] => 5
                            [post_date] => 2023-04-20 08:00:35
                            [post_date_gmt] => 2023-04-20 08:00:35
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:15:10
                            [post_modified_gmt] => 2023-06-27 13:15:10
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9886
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [88] => WP_Post Object
                        (
                            [ID] => 9885
                            [post_author] => 5
                            [post_date] => 2023-04-19 15:03:20
                            [post_date_gmt] => 2023-04-19 15:03:20
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 09:26:02
                            [post_modified_gmt] => 2024-01-11 09:26:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9885
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [89] => WP_Post Object
                        (
                            [ID] => 9884
                            [post_author] => 5
                            [post_date] => 2023-04-19 14:28:15
                            [post_date_gmt] => 2023-04-19 14:28:15
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 08:21:50
                            [post_modified_gmt] => 2023-10-17 08:21:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9884
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [90] => WP_Post Object
                        (
                            [ID] => 9883
                            [post_author] => 5
                            [post_date] => 2023-04-19 13:59:07
                            [post_date_gmt] => 2023-04-19 13:59:07
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 08:19:57
                            [post_modified_gmt] => 2023-10-17 08:19:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9883
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [91] => WP_Post Object
                        (
                            [ID] => 9882
                            [post_author] => 5
                            [post_date] => 2023-04-19 13:38:50
                            [post_date_gmt] => 2023-04-19 13:38:50
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:12:35
                            [post_modified_gmt] => 2023-06-27 13:12:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9882
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [92] => WP_Post Object
                        (
                            [ID] => 9881
                            [post_author] => 5
                            [post_date] => 2023-04-19 13:28:03
                            [post_date_gmt] => 2023-04-19 13:28:03
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:29:59
                            [post_modified_gmt] => 2023-06-27 13:29:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9881
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [93] => WP_Post Object
                        (
                            [ID] => 9880
                            [post_author] => 5
                            [post_date] => 2023-04-19 13:15:50
                            [post_date_gmt] => 2023-04-19 13:15:50
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 11:54:53
                            [post_modified_gmt] => 2023-06-27 11:54:53
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9880
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [94] => WP_Post Object
                        (
                            [ID] => 9879
                            [post_author] => 5
                            [post_date] => 2023-04-19 13:00:06
                            [post_date_gmt] => 2023-04-19 13:00:06
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 10:49:06
                            [post_modified_gmt] => 2024-09-04 10:49:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9879
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [95] => WP_Post Object
                        (
                            [ID] => 9877
                            [post_author] => 5
                            [post_date] => 2023-04-19 11:54:25
                            [post_date_gmt] => 2023-04-19 11:54:25
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-10 14:12:20
                            [post_modified_gmt] => 2023-11-10 14:12:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9877
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [96] => WP_Post Object
                        (
                            [ID] => 9875
                            [post_author] => 5
                            [post_date] => 2023-04-19 10:41:01
                            [post_date_gmt] => 2023-04-19 10:41:01
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 11:59:40
                            [post_modified_gmt] => 2023-06-27 11:59:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9875
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [97] => WP_Post Object
                        (
                            [ID] => 9874
                            [post_author] => 5
                            [post_date] => 2023-04-18 15:17:41
                            [post_date_gmt] => 2023-04-18 15:17:41
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 11:50:00
                            [post_modified_gmt] => 2023-06-27 11:50:00
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9874
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [98] => WP_Post Object
                        (
                            [ID] => 9873
                            [post_author] => 5
                            [post_date] => 2023-04-18 14:52:22
                            [post_date_gmt] => 2023-04-18 14:52:22
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-28 12:40:40
                            [post_modified_gmt] => 2024-10-28 12:40:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9873
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [99] => WP_Post Object
                        (
                            [ID] => 9872
                            [post_author] => 5
                            [post_date] => 2023-04-18 13:17:39
                            [post_date_gmt] => 2023-04-18 13:17:39
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:24:05
                            [post_modified_gmt] => 2023-06-27 14:24:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9872
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [100] => WP_Post Object
                        (
                            [ID] => 9871
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:57:25
                            [post_date_gmt] => 2023-04-18 10:57:25
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:25:17
                            [post_modified_gmt] => 2023-06-27 14:25:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9871
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [101] => WP_Post Object
                        (
                            [ID] => 9870
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:46:43
                            [post_date_gmt] => 2023-04-18 10:46:43
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:24:37
                            [post_modified_gmt] => 2023-06-27 14:24:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9870
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [102] => WP_Post Object
                        (
                            [ID] => 9869
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:43:52
                            [post_date_gmt] => 2023-04-18 10:43:52
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:19:16
                            [post_modified_gmt] => 2023-06-27 14:19:16
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9869
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [103] => WP_Post Object
                        (
                            [ID] => 9868
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:40:41
                            [post_date_gmt] => 2023-04-18 10:40:41
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:20:07
                            [post_modified_gmt] => 2023-06-27 14:20:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9868
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [104] => WP_Post Object
                        (
                            [ID] => 9867
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:21:23
                            [post_date_gmt] => 2023-04-18 10:21:23
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:02:27
                            [post_modified_gmt] => 2023-06-27 14:02:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9867
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [105] => WP_Post Object
                        (
                            [ID] => 9866
                            [post_author] => 5
                            [post_date] => 2023-04-18 10:10:55
                            [post_date_gmt] => 2023-04-18 10:10:55
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:59:41
                            [post_modified_gmt] => 2023-06-27 13:59:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9866
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [106] => WP_Post Object
                        (
                            [ID] => 9865
                            [post_author] => 5
                            [post_date] => 2023-04-18 09:13:30
                            [post_date_gmt] => 2023-04-18 09:13:30
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 08:25:18
                            [post_modified_gmt] => 2023-10-17 08:25:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9865
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [107] => WP_Post Object
                        (
                            [ID] => 9863
                            [post_author] => 5
                            [post_date] => 2023-04-18 08:21:11
                            [post_date_gmt] => 2023-04-18 08:21:11
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 08:24:50
                            [post_modified_gmt] => 2023-10-17 08:24:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9863
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [108] => WP_Post Object
                        (
                            [ID] => 9864
                            [post_author] => 5
                            [post_date] => 2023-04-18 07:54:00
                            [post_date_gmt] => 2023-04-18 07:54:00
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 14:08:29
                            [post_modified_gmt] => 2023-06-27 14:08:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9864
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [109] => WP_Post Object
                        (
                            [ID] => 9862
                            [post_author] => 5
                            [post_date] => 2023-04-17 14:28:56
                            [post_date_gmt] => 2023-04-17 14:28:56
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:49:26
                            [post_modified_gmt] => 2023-06-27 13:49:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9862
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [110] => WP_Post Object
                        (
                            [ID] => 9861
                            [post_author] => 5
                            [post_date] => 2023-04-17 14:18:47
                            [post_date_gmt] => 2023-04-17 14:18:47
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:48:20
                            [post_modified_gmt] => 2023-06-27 13:48:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9861
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [111] => WP_Post Object
                        (
                            [ID] => 9860
                            [post_author] => 5
                            [post_date] => 2023-04-14 14:35:29
                            [post_date_gmt] => 2023-04-14 14:35:29
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-10 14:12:45
                            [post_modified_gmt] => 2023-11-10 14:12:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9860
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [112] => WP_Post Object
                        (
                            [ID] => 9859
                            [post_author] => 5
                            [post_date] => 2023-04-14 13:08:09
                            [post_date_gmt] => 2023-04-14 13:08:09
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:45:17
                            [post_modified_gmt] => 2023-06-27 13:45:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9859
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [113] => WP_Post Object
                        (
                            [ID] => 6333
                            [post_author] => 5
                            [post_date] => 2022-10-27 15:17:29
                            [post_date_gmt] => 2022-10-27 15:17:29
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:51:02
                            [post_modified_gmt] => 2024-04-08 12:51:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6333
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [114] => WP_Post Object
                        (
                            [ID] => 6332
                            [post_author] => 5
                            [post_date] => 2022-10-27 15:11:17
                            [post_date_gmt] => 2022-10-27 15:11:17
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:53:01
                            [post_modified_gmt] => 2024-04-08 12:53:01
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6332
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [115] => WP_Post Object
                        (
                            [ID] => 6330
                            [post_author] => 5
                            [post_date] => 2022-10-27 15:05:13
                            [post_date_gmt] => 2022-10-27 15:05:13
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:52:22
                            [post_modified_gmt] => 2024-04-08 12:52:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6330
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [116] => WP_Post Object
                        (
                            [ID] => 6329
                            [post_author] => 5
                            [post_date] => 2022-10-27 11:59:35
                            [post_date_gmt] => 2022-10-27 11:59:35
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:49:56
                            [post_modified_gmt] => 2024-04-08 12:49:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6329
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [117] => WP_Post Object
                        (
                            [ID] => 6328
                            [post_author] => 5
                            [post_date] => 2022-10-27 11:49:09
                            [post_date_gmt] => 2022-10-27 11:49:09
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:50:18
                            [post_modified_gmt] => 2024-04-08 12:50:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6328
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [118] => WP_Post Object
                        (
                            [ID] => 6327
                            [post_author] => 5
                            [post_date] => 2022-10-27 11:45:45
                            [post_date_gmt] => 2022-10-27 11:45:45
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 16:27:41
                            [post_modified_gmt] => 2023-12-20 16:27:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6327
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [119] => WP_Post Object
                        (
                            [ID] => 6326
                            [post_author] => 5
                            [post_date] => 2022-10-27 11:13:28
                            [post_date_gmt] => 2022-10-27 11:13:28
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-08-20 15:57:40
                            [post_modified_gmt] => 2024-08-20 15:57:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6326
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [120] => WP_Post Object
                        (
                            [ID] => 6325
                            [post_author] => 5
                            [post_date] => 2022-10-27 10:57:10
                            [post_date_gmt] => 2022-10-27 10:57:10
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 15:15:37
                            [post_modified_gmt] => 2023-10-17 15:15:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6325
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [121] => WP_Post Object
                        (
                            [ID] => 6324
                            [post_author] => 5
                            [post_date] => 2022-10-27 10:23:50
                            [post_date_gmt] => 2022-10-27 10:23:50
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 15:18:21
                            [post_modified_gmt] => 2023-10-17 15:18:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6324
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [122] => WP_Post Object
                        (
                            [ID] => 6323
                            [post_author] => 5
                            [post_date] => 2022-10-27 09:37:11
                            [post_date_gmt] => 2022-10-27 09:37:11
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 15:19:39
                            [post_modified_gmt] => 2023-10-17 15:19:39
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6323
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [123] => WP_Post Object
                        (
                            [ID] => 6322
                            [post_author] => 5
                            [post_date] => 2022-10-27 09:13:33
                            [post_date_gmt] => 2022-10-27 09:13:33
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 09:36:54
                            [post_modified_gmt] => 2024-01-11 09:36:54
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6322
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [124] => WP_Post Object
                        (
                            [ID] => 6319
                            [post_author] => 5
                            [post_date] => 2022-10-26 13:16:20
                            [post_date_gmt] => 2022-10-26 13:16:20
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 16:18:29
                            [post_modified_gmt] => 2023-12-20 16:18:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6319
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [125] => WP_Post Object
                        (
                            [ID] => 6318
                            [post_author] => 5
                            [post_date] => 2022-10-26 13:08:20
                            [post_date_gmt] => 2022-10-26 13:08:20
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 15:21:30
                            [post_modified_gmt] => 2023-10-17 15:21:30
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6318
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [126] => WP_Post Object
                        (
                            [ID] => 6317
                            [post_author] => 5
                            [post_date] => 2022-10-26 12:22:38
                            [post_date_gmt] => 2022-10-26 12:22:38
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-10 14:13:25
                            [post_modified_gmt] => 2023-11-10 14:13:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6317
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [127] => WP_Post Object
                        (
                            [ID] => 6316
                            [post_author] => 5
                            [post_date] => 2022-10-26 11:26:56
                            [post_date_gmt] => 2022-10-26 11:26:56
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 16:22:59
                            [post_modified_gmt] => 2023-12-20 16:22:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6316
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [128] => WP_Post Object
                        (
                            [ID] => 6315
                            [post_author] => 5
                            [post_date] => 2022-10-26 10:20:15
                            [post_date_gmt] => 2022-10-26 10:20:15
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 16:26:54
                            [post_modified_gmt] => 2023-12-20 16:26:54
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6315
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [129] => WP_Post Object
                        (
                            [ID] => 6314
                            [post_author] => 5
                            [post_date] => 2022-10-26 10:01:08
                            [post_date_gmt] => 2022-10-26 10:01:08
                            [post_content] => 
                            [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 16:24:52
                            [post_modified_gmt] => 2023-12-20 16:24:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=6314
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [130] => WP_Post Object
                        (
                            [ID] => 5809
                            [post_author] => 5
                            [post_date] => 2022-10-05 07:50:36
                            [post_date_gmt] => 2022-10-05 07:50:36
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:22:58
                            [post_modified_gmt] => 2024-09-23 10:22:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5809
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [131] => WP_Post Object
                        (
                            [ID] => 5700
                            [post_author] => 5
                            [post_date] => 2022-09-07 11:00:26
                            [post_date_gmt] => 2022-09-07 11:00:26
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:43:35
                            [post_modified_gmt] => 2023-06-20 09:43:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5700
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [132] => WP_Post Object
                        (
                            [ID] => 5699
                            [post_author] => 5
                            [post_date] => 2022-09-07 10:28:24
                            [post_date_gmt] => 2022-09-07 10:28:24
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:47:41
                            [post_modified_gmt] => 2023-06-20 09:47:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5699
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [133] => WP_Post Object
                        (
                            [ID] => 5698
                            [post_author] => 5
                            [post_date] => 2022-09-07 10:14:27
                            [post_date_gmt] => 2022-09-07 10:14:27
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:44:42
                            [post_modified_gmt] => 2023-06-20 09:44:42
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5698
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [134] => WP_Post Object
                        (
                            [ID] => 5697
                            [post_author] => 5
                            [post_date] => 2022-09-07 10:01:19
                            [post_date_gmt] => 2022-09-07 10:01:19
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 06:47:05
                            [post_modified_gmt] => 2023-06-20 06:47:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5697
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [135] => WP_Post Object
                        (
                            [ID] => 5696
                            [post_author] => 5
                            [post_date] => 2022-09-07 09:45:07
                            [post_date_gmt] => 2022-09-07 09:45:07
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 06:39:46
                            [post_modified_gmt] => 2023-06-20 06:39:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5696
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [136] => WP_Post Object
                        (
                            [ID] => 5695
                            [post_author] => 5
                            [post_date] => 2022-09-07 09:35:25
                            [post_date_gmt] => 2022-09-07 09:35:25
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 06:33:29
                            [post_modified_gmt] => 2023-06-20 06:33:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5695
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [137] => WP_Post Object
                        (
                            [ID] => 5694
                            [post_author] => 5
                            [post_date] => 2022-09-07 09:11:50
                            [post_date_gmt] => 2022-09-07 09:11:50
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:20:43
                            [post_modified_gmt] => 2023-06-19 15:20:43
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5694
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [138] => WP_Post Object
                        (
                            [ID] => 5693
                            [post_author] => 5
                            [post_date] => 2022-09-07 08:51:55
                            [post_date_gmt] => 2022-09-07 08:51:55
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:22:50
                            [post_modified_gmt] => 2023-06-19 15:22:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5693
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [139] => WP_Post Object
                        (
                            [ID] => 5692
                            [post_author] => 5
                            [post_date] => 2022-09-07 08:21:55
                            [post_date_gmt] => 2022-09-07 08:21:55
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:15:19
                            [post_modified_gmt] => 2023-10-17 10:15:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5692
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [140] => WP_Post Object
                        (
                            [ID] => 5691
                            [post_author] => 5
                            [post_date] => 2022-09-07 08:12:00
                            [post_date_gmt] => 2022-09-07 08:12:00
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:27:09
                            [post_modified_gmt] => 2023-06-19 15:27:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5691
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [141] => WP_Post Object
                        (
                            [ID] => 5690
                            [post_author] => 5
                            [post_date] => 2022-09-06 18:19:25
                            [post_date_gmt] => 2022-09-06 18:19:25
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-09-06 18:19:25
                            [post_modified_gmt] => 2022-09-06 18:19:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5690
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [142] => WP_Post Object
                        (
                            [ID] => 5689
                            [post_author] => 5
                            [post_date] => 2022-09-06 18:09:28
                            [post_date_gmt] => 2022-09-06 18:09:28
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:24:14
                            [post_modified_gmt] => 2023-06-19 15:24:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5689
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [143] => WP_Post Object
                        (
                            [ID] => 5688
                            [post_author] => 5
                            [post_date] => 2022-09-06 13:35:23
                            [post_date_gmt] => 2022-09-06 13:35:23
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:17:59
                            [post_modified_gmt] => 2023-06-19 15:17:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5688
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [144] => WP_Post Object
                        (
                            [ID] => 5684
                            [post_author] => 5
                            [post_date] => 2022-09-06 13:25:46
                            [post_date_gmt] => 2022-09-06 13:25:46
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:19:28
                            [post_modified_gmt] => 2023-06-19 15:19:28
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5684
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [145] => WP_Post Object
                        (
                            [ID] => 5683
                            [post_author] => 5
                            [post_date] => 2022-09-06 13:02:35
                            [post_date_gmt] => 2022-09-06 13:02:35
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:18:57
                            [post_modified_gmt] => 2023-10-17 10:18:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5683
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [146] => WP_Post Object
                        (
                            [ID] => 5682
                            [post_author] => 5
                            [post_date] => 2022-09-06 12:46:39
                            [post_date_gmt] => 2022-09-06 12:46:39
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 15:34:15
                            [post_modified_gmt] => 2023-06-19 15:34:15
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5682
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [147] => WP_Post Object
                        (
                            [ID] => 5681
                            [post_author] => 5
                            [post_date] => 2022-09-06 12:09:51
                            [post_date_gmt] => 2022-09-06 12:09:51
                            [post_content] => 
                            [post_title] => Alnylam Pharmaceuticals - University of British Columbia- AlCana Technology, Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:16:35
                            [post_modified_gmt] => 2023-10-17 10:16:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5681
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [148] => WP_Post Object
                        (
                            [ID] => 5429
                            [post_author] => 5
                            [post_date] => 2022-07-25 06:51:00
                            [post_date_gmt] => 2022-07-25 06:51:00
                            [post_content] => 
                            [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => sanofi-translate-bio-influenza-and-covid-19-vaccine-collaboration-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:56:54
                            [post_modified_gmt] => 2024-09-23 10:56:54
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5429
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [149] => WP_Post Object
                        (
                            [ID] => 4894
                            [post_author] => 5
                            [post_date] => 2022-06-08 13:01:48
                            [post_date_gmt] => 2022-06-08 13:01:48
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-06-09 12:23:23
                            [post_modified_gmt] => 2022-06-09 12:23:23
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4894
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [150] => WP_Post Object
                        (
                            [ID] => 4893
                            [post_author] => 5
                            [post_date] => 2022-06-08 12:28:46
                            [post_date_gmt] => 2022-06-08 12:28:46
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 10:50:20
                            [post_modified_gmt] => 2024-09-04 10:50:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4893
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [151] => WP_Post Object
                        (
                            [ID] => 4892
                            [post_author] => 5
                            [post_date] => 2022-06-08 11:21:42
                            [post_date_gmt] => 2022-06-08 11:21:42
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-24 12:58:23
                            [post_modified_gmt] => 2023-11-24 12:58:23
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4892
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [152] => WP_Post Object
                        (
                            [ID] => 4891
                            [post_author] => 5
                            [post_date] => 2022-06-08 10:28:17
                            [post_date_gmt] => 2022-06-08 10:28:17
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:33:47
                            [post_modified_gmt] => 2024-01-09 10:33:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4891
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [153] => WP_Post Object
                        (
                            [ID] => 4890
                            [post_author] => 5
                            [post_date] => 2022-06-08 10:10:04
                            [post_date_gmt] => 2022-06-08 10:10:04
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:36:54
                            [post_modified_gmt] => 2024-01-09 10:36:54
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4890
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [154] => WP_Post Object
                        (
                            [ID] => 4889
                            [post_author] => 5
                            [post_date] => 2022-06-08 10:04:27
                            [post_date_gmt] => 2022-06-08 10:04:27
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:36:06
                            [post_modified_gmt] => 2024-01-09 10:36:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4889
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [155] => WP_Post Object
                        (
                            [ID] => 4888
                            [post_author] => 5
                            [post_date] => 2022-06-08 09:09:43
                            [post_date_gmt] => 2022-06-08 09:09:43
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:26:14
                            [post_modified_gmt] => 2024-01-09 10:26:14
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4888
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [156] => WP_Post Object
                        (
                            [ID] => 4886
                            [post_author] => 5
                            [post_date] => 2022-06-08 08:43:51
                            [post_date_gmt] => 2022-06-08 08:43:51
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:23:35
                            [post_modified_gmt] => 2024-01-09 10:23:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4886
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [157] => WP_Post Object
                        (
                            [ID] => 4885
                            [post_author] => 5
                            [post_date] => 2022-06-08 08:36:01
                            [post_date_gmt] => 2022-06-08 08:36:01
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-09 10:22:26
                            [post_modified_gmt] => 2024-01-09 10:22:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4885
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [158] => WP_Post Object
                        (
                            [ID] => 4884
                            [post_author] => 5
                            [post_date] => 2022-06-08 07:54:05
                            [post_date_gmt] => 2022-06-08 07:54:05
                            [post_content] => 
                            [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-06-09 12:24:23
                            [post_modified_gmt] => 2022-06-09 12:24:23
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4884
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [159] => WP_Post Object
                        (
                            [ID] => 4883
                            [post_author] => 5
                            [post_date] => 2022-06-08 07:25:31
                            [post_date_gmt] => 2022-06-08 07:25:31
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 10:02:41
                            [post_modified_gmt] => 2024-01-11 10:02:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4883
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [160] => WP_Post Object
                        (
                            [ID] => 4882
                            [post_author] => 5
                            [post_date] => 2022-06-08 07:14:04
                            [post_date_gmt] => 2022-06-08 07:14:04
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 10:03:08
                            [post_modified_gmt] => 2024-01-11 10:03:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4882
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [161] => WP_Post Object
                        (
                            [ID] => 4881
                            [post_author] => 5
                            [post_date] => 2022-06-07 13:58:33
                            [post_date_gmt] => 2022-06-07 13:58:33
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-06-09 12:25:30
                            [post_modified_gmt] => 2022-06-09 12:25:30
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4881
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [162] => WP_Post Object
                        (
                            [ID] => 4878
                            [post_author] => 5
                            [post_date] => 2022-06-07 13:47:24
                            [post_date_gmt] => 2022-06-07 13:47:24
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-12 12:49:28
                            [post_modified_gmt] => 2022-10-12 12:49:28
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4878
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [163] => WP_Post Object
                        (
                            [ID] => 4877
                            [post_author] => 5
                            [post_date] => 2022-06-07 13:22:01
                            [post_date_gmt] => 2022-06-07 13:22:01
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-24 12:56:46
                            [post_modified_gmt] => 2023-11-24 12:56:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4877
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [164] => WP_Post Object
                        (
                            [ID] => 4876
                            [post_author] => 5
                            [post_date] => 2022-06-07 13:03:57
                            [post_date_gmt] => 2022-06-07 13:03:57
                            [post_content] => 
                            [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:09:47
                            [post_modified_gmt] => 2023-10-17 10:09:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4876
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [165] => WP_Post Object
                        (
                            [ID] => 4875
                            [post_author] => 5
                            [post_date] => 2022-06-07 11:48:34
                            [post_date_gmt] => 2022-06-07 11:48:34
                            [post_content] => 
                            [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 09:55:38
                            [post_modified_gmt] => 2023-10-17 09:55:38
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4875
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [166] => WP_Post Object
                        (
                            [ID] => 4873
                            [post_author] => 5
                            [post_date] => 2022-06-07 11:31:58
                            [post_date_gmt] => 2022-06-07 11:31:58
                            [post_content] => 
                            [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => entasis-dndi-gardp-gonorrhea-medication-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-11 10:03:37
                            [post_modified_gmt] => 2024-01-11 10:03:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4873
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [167] => WP_Post Object
                        (
                            [ID] => 4113
                            [post_author] => 5
                            [post_date] => 2022-01-19 09:21:03
                            [post_date_gmt] => 2022-01-19 09:21:03
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-inter-institutional-research-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:57:07
                            [post_modified_gmt] => 2023-06-20 09:57:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4113
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [168] => WP_Post Object
                        (
                            [ID] => 4112
                            [post_author] => 5
                            [post_date] => 2022-01-18 14:43:23
                            [post_date_gmt] => 2022-01-18 14:43:23
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-inter-institutional-research-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 10:19:08
                            [post_modified_gmt] => 2023-06-20 10:19:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4112
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [169] => WP_Post Object
                        (
                            [ID] => 4105
                            [post_author] => 5
                            [post_date] => 2022-01-18 13:30:40
                            [post_date_gmt] => 2022-01-18 13:30:40
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-inter-institutional-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:48:25
                            [post_modified_gmt] => 2023-06-20 09:48:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4105
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [170] => WP_Post Object
                        (
                            [ID] => 4098
                            [post_author] => 5
                            [post_date] => 2022-01-12 14:27:12
                            [post_date_gmt] => 2022-01-12 14:27:12
                            [post_content] => 
                            [post_title] => Academic Institution – Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-01-12 14:27:12
                            [post_modified_gmt] => 2022-01-12 14:27:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4098
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [171] => WP_Post Object
                        (
                            [ID] => 4095
                            [post_author] => 5
                            [post_date] => 2022-01-12 13:39:41
                            [post_date_gmt] => 2022-01-12 13:39:41
                            [post_content] => 
                            [post_title] => Academic Institution – Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-16 14:18:59
                            [post_modified_gmt] => 2023-10-16 14:18:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4095
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [172] => WP_Post Object
                        (
                            [ID] => 4094
                            [post_author] => 5
                            [post_date] => 2022-01-12 13:19:48
                            [post_date_gmt] => 2022-01-12 13:19:48
                            [post_content] => 
                            [post_title] => Academic Institution – Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:49:13
                            [post_modified_gmt] => 2023-06-21 07:49:13
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4094
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [173] => WP_Post Object
                        (
                            [ID] => 4093
                            [post_author] => 5
                            [post_date] => 2022-01-12 13:01:38
                            [post_date_gmt] => 2022-01-12 13:01:38
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:47:57
                            [post_modified_gmt] => 2023-06-21 07:47:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4093
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [174] => WP_Post Object
                        (
                            [ID] => 4092
                            [post_author] => 5
                            [post_date] => 2022-01-12 12:33:49
                            [post_date_gmt] => 2022-01-12 12:33:49
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:46:13
                            [post_modified_gmt] => 2023-06-21 07:46:13
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4092
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [175] => WP_Post Object
                        (
                            [ID] => 4090
                            [post_author] => 5
                            [post_date] => 2022-01-12 11:48:32
                            [post_date_gmt] => 2022-01-12 11:48:32
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => academic-institution-company-research-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:42:34
                            [post_modified_gmt] => 2023-06-21 07:42:34
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4090
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [176] => WP_Post Object
                        (
                            [ID] => 4066
                            [post_author] => 5
                            [post_date] => 2022-01-07 11:35:15
                            [post_date_gmt] => 2022-01-07 11:35:15
                            [post_content] => 
                            [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:31:50
                            [post_modified_gmt] => 2024-09-23 10:31:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4066
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [177] => WP_Post Object
                        (
                            [ID] => 4065
                            [post_author] => 5
                            [post_date] => 2022-01-07 11:21:06
                            [post_date_gmt] => 2022-01-07 11:21:06
                            [post_content] => 
                            [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:33:48
                            [post_modified_gmt] => 2024-09-23 10:33:48
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4065
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [178] => WP_Post Object
                        (
                            [ID] => 4064
                            [post_author] => 5
                            [post_date] => 2022-01-07 10:57:29
                            [post_date_gmt] => 2022-01-07 10:57:29
                            [post_content] => 
                            [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:34:53
                            [post_modified_gmt] => 2024-09-23 10:34:53
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4064
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [179] => WP_Post Object
                        (
                            [ID] => 4063
                            [post_author] => 5
                            [post_date] => 2022-01-07 10:34:51
                            [post_date_gmt] => 2022-01-07 10:34:51
                            [post_content] => 
                            [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:25:43
                            [post_modified_gmt] => 2024-09-23 10:25:43
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4063
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [180] => WP_Post Object
                        (
                            [ID] => 4062
                            [post_author] => 5
                            [post_date] => 2022-01-07 10:03:12
                            [post_date_gmt] => 2022-01-07 10:03:12
                            [post_content] => 
                            [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:30:50
                            [post_modified_gmt] => 2024-09-23 10:30:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4062
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [181] => WP_Post Object
                        (
                            [ID] => 4061
                            [post_author] => 5
                            [post_date] => 2022-01-07 09:46:42
                            [post_date_gmt] => 2022-01-07 09:46:42
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:24:42
                            [post_modified_gmt] => 2024-09-23 10:24:42
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4061
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [182] => WP_Post Object
                        (
                            [ID] => 4060
                            [post_author] => 5
                            [post_date] => 2022-01-07 09:40:49
                            [post_date_gmt] => 2022-01-07 09:40:49
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => path-aridis-rotavirus-vaccine-development-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:21:47
                            [post_modified_gmt] => 2023-10-17 10:21:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4060
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [183] => WP_Post Object
                        (
                            [ID] => 4024
                            [post_author] => 5
                            [post_date] => 2021-12-15 15:33:17
                            [post_date_gmt] => 2021-12-15 15:33:17
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-22
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:25:41
                            [post_modified_gmt] => 2024-04-08 12:25:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4024
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [184] => WP_Post Object
                        (
                            [ID] => 4022
                            [post_author] => 5
                            [post_date] => 2021-12-15 14:49:36
                            [post_date_gmt] => 2021-12-15 14:49:36
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-20
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:45:30
                            [post_modified_gmt] => 2024-04-08 12:45:30
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4022
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [185] => WP_Post Object
                        (
                            [ID] => 4021
                            [post_author] => 5
                            [post_date] => 2021-12-15 14:31:00
                            [post_date_gmt] => 2021-12-15 14:31:00
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-19
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:47:16
                            [post_modified_gmt] => 2024-04-08 12:47:16
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4021
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [186] => WP_Post Object
                        (
                            [ID] => 4020
                            [post_author] => 5
                            [post_date] => 2021-12-15 14:24:47
                            [post_date_gmt] => 2021-12-15 14:24:47
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-18
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:46:03
                            [post_modified_gmt] => 2024-04-08 12:46:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4020
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [187] => WP_Post Object
                        (
                            [ID] => 4017
                            [post_author] => 5
                            [post_date] => 2021-12-15 13:22:49
                            [post_date_gmt] => 2021-12-15 13:22:49
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:27:29
                            [post_modified_gmt] => 2024-04-08 12:27:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4017
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [188] => WP_Post Object
                        (
                            [ID] => 4016
                            [post_author] => 5
                            [post_date] => 2021-12-15 13:20:07
                            [post_date_gmt] => 2021-12-15 13:20:07
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 12:24:47
                            [post_modified_gmt] => 2024-04-08 12:24:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4016
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [189] => WP_Post Object
                        (
                            [ID] => 4014
                            [post_author] => 5
                            [post_date] => 2021-12-15 12:33:09
                            [post_date_gmt] => 2021-12-15 12:33:09
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 14:58:11
                            [post_modified_gmt] => 2023-09-27 14:58:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4014
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [190] => WP_Post Object
                        (
                            [ID] => 4013
                            [post_author] => 5
                            [post_date] => 2021-12-15 12:16:20
                            [post_date_gmt] => 2021-12-15 12:16:20
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 12:14:58
                            [post_modified_gmt] => 2023-09-27 12:14:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4013
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [191] => WP_Post Object
                        (
                            [ID] => 4011
                            [post_author] => 5
                            [post_date] => 2021-12-14 15:21:54
                            [post_date_gmt] => 2021-12-14 15:21:54
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 15:31:35
                            [post_modified_gmt] => 2023-09-27 15:31:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4011
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [192] => WP_Post Object
                        (
                            [ID] => 4009
                            [post_author] => 5
                            [post_date] => 2021-12-14 15:10:51
                            [post_date_gmt] => 2021-12-14 15:10:51
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-and-gsk-collaboration-and-license-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 11:47:52
                            [post_modified_gmt] => 2023-09-27 11:47:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4009
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [193] => WP_Post Object
                        (
                            [ID] => 4007
                            [post_author] => 5
                            [post_date] => 2021-12-14 08:51:32
                            [post_date_gmt] => 2021-12-14 08:51:32
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 10:48:30
                            [post_modified_gmt] => 2024-09-04 10:48:30
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4007
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [194] => WP_Post Object
                        (
                            [ID] => 4006
                            [post_author] => 5
                            [post_date] => 2021-12-14 08:16:01
                            [post_date_gmt] => 2021-12-14 08:16:01
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 15:02:09
                            [post_modified_gmt] => 2023-09-27 15:02:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4006
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [195] => WP_Post Object
                        (
                            [ID] => 4004
                            [post_author] => 5
                            [post_date] => 2021-12-14 07:57:41
                            [post_date_gmt] => 2021-12-14 07:57:41
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 11:52:42
                            [post_modified_gmt] => 2023-09-27 11:52:42
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4004
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [196] => WP_Post Object
                        (
                            [ID] => 4003
                            [post_author] => 5
                            [post_date] => 2021-12-13 18:36:53
                            [post_date_gmt] => 2021-12-13 18:36:53
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 14:52:45
                            [post_modified_gmt] => 2023-09-27 14:52:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4003
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [197] => WP_Post Object
                        (
                            [ID] => 4002
                            [post_author] => 5
                            [post_date] => 2021-12-13 18:28:05
                            [post_date_gmt] => 2021-12-13 18:28:05
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-08-20 15:56:24
                            [post_modified_gmt] => 2024-08-20 15:56:24
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4002
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [198] => WP_Post Object
                        (
                            [ID] => 4001
                            [post_author] => 5
                            [post_date] => 2021-12-13 14:55:46
                            [post_date_gmt] => 2021-12-13 14:55:46
                            [post_content] => 
                            [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 15:20:07
                            [post_modified_gmt] => 2023-09-27 15:20:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4001
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [199] => WP_Post Object
                        (
                            [ID] => 3997
                            [post_author] => 5
                            [post_date] => 2021-12-13 14:24:49
                            [post_date_gmt] => 2021-12-13 14:24:49
                            [post_content] => 
                            [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 15:35:24
                            [post_modified_gmt] => 2023-09-27 15:35:24
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=3997
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [200] => WP_Post Object
                        (
                            [ID] => 3698
                            [post_author] => 5
                            [post_date] => 2021-08-19 14:33:22
                            [post_date_gmt] => 2021-08-19 14:33:22
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-inter-institutional-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:50:03
                            [post_modified_gmt] => 2023-06-20 09:50:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=3698
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [201] => WP_Post Object
                        (
                            [ID] => 2972
                            [post_author] => 5
                            [post_date] => 2021-06-01 10:17:19
                            [post_date_gmt] => 2021-06-01 10:17:19
                            [post_content] => 
                            [post_title] => WHO Template Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => who-template-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-01-27 11:59:00
                            [post_modified_gmt] => 2022-01-27 11:59:00
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=2972
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [202] => WP_Post Object
                        (
                            [ID] => 2426
                            [post_author] => 5
                            [post_date] => 2020-12-14 15:02:08
                            [post_date_gmt] => 2020-12-14 15:02:08
                            [post_content] => 
                            [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => sanofi-translate-bio-collaboration-and-license-agreement-as-amended-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 11:46:38
                            [post_modified_gmt] => 2024-09-23 11:46:38
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=2426
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [203] => WP_Post Object
                        (
                            [ID] => 2424
                            [post_author] => 5
                            [post_date] => 2020-12-14 15:01:40
                            [post_date_gmt] => 2020-12-14 15:01:40
                            [post_content] => 
                            [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => sanofi-translate-bio-collaboration-and-license-agreement-as-amended-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 12:02:47
                            [post_modified_gmt] => 2024-09-23 12:02:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=2424
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [204] => WP_Post Object
                        (
                            [ID] => 1309
                            [post_author] => 7
                            [post_date] => 2020-05-23 17:17:44
                            [post_date_gmt] => 2020-05-23 17:17:44
                            [post_content] => 
                            [post_title] => IMI 2 Joint Undertaking  Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2joint-undertaking-model-consortium-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 15:58:19
                            [post_modified_gmt] => 2024-09-19 15:58:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1309
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [205] => WP_Post Object
                        (
                            [ID] => 1287
                            [post_author] => 6
                            [post_date] => 2020-05-22 23:05:30
                            [post_date_gmt] => 2020-05-22 23:05:30
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-07 13:56:00
                            [post_modified_gmt] => 2024-11-07 13:56:00
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1287
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [206] => WP_Post Object
                        (
                            [ID] => 1285
                            [post_author] => 6
                            [post_date] => 2020-05-22 23:01:07
                            [post_date_gmt] => 2020-05-22 23:01:07
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-07 15:04:45
                            [post_modified_gmt] => 2024-11-07 15:04:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1285
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [207] => WP_Post Object
                        (
                            [ID] => 1283
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:57:44
                            [post_date_gmt] => 2020-05-22 22:57:44
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:36:58
                            [post_modified_gmt] => 2024-09-23 10:36:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1283
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [208] => WP_Post Object
                        (
                            [ID] => 1282
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:56:18
                            [post_date_gmt] => 2020-05-22 22:56:18
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-19 14:57:56
                            [post_modified_gmt] => 2023-06-19 14:57:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1282
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [209] => WP_Post Object
                        (
                            [ID] => 1281
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:55:22
                            [post_date_gmt] => 2020-05-22 22:55:22
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:33:38
                            [post_modified_gmt] => 2024-09-20 07:33:38
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1281
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [210] => WP_Post Object
                        (
                            [ID] => 1280
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:54:32
                            [post_date_gmt] => 2020-05-22 22:54:32
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-iia-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 10:24:28
                            [post_modified_gmt] => 2023-06-20 10:24:28
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1280
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [211] => WP_Post Object
                        (
                            [ID] => 1275
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:39:41
                            [post_date_gmt] => 2020-05-22 22:39:41
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:33:11
                            [post_modified_gmt] => 2024-09-23 10:33:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1275
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [212] => WP_Post Object
                        (
                            [ID] => 1273
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:37:54
                            [post_date_gmt] => 2020-05-22 22:37:54
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-iia-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 10:15:03
                            [post_modified_gmt] => 2023-06-20 10:15:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1273
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [213] => WP_Post Object
                        (
                            [ID] => 1267
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:26:39
                            [post_date_gmt] => 2020-05-22 22:26:39
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-07 13:11:30
                            [post_modified_gmt] => 2024-11-07 13:11:30
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1267
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [214] => WP_Post Object
                        (
                            [ID] => 1266
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:25:16
                            [post_date_gmt] => 2020-05-22 22:25:16
                            [post_content] => 
                            [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2-joint-undertaking-model-consortium-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 16:01:08
                            [post_modified_gmt] => 2024-09-19 16:01:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1266
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [215] => WP_Post Object
                        (
                            [ID] => 1262
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:18:41
                            [post_date_gmt] => 2020-05-22 22:18:41
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:21:26
                            [post_modified_gmt] => 2024-09-20 07:21:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1262
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [216] => WP_Post Object
                        (
                            [ID] => 1259
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:04:31
                            [post_date_gmt] => 2020-05-22 22:04:31
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 10:17:15
                            [post_modified_gmt] => 2023-06-20 10:17:15
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1259
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [217] => WP_Post Object
                        (
                            [ID] => 1258
                            [post_author] => 6
                            [post_date] => 2020-05-22 22:03:08
                            [post_date_gmt] => 2020-05-22 22:03:08
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:32:39
                            [post_modified_gmt] => 2024-09-20 07:32:39
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1258
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [218] => WP_Post Object
                        (
                            [ID] => 1248
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:36:47
                            [post_date_gmt] => 2020-05-22 21:36:47
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:42:59
                            [post_modified_gmt] => 2023-06-21 07:42:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1248
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [219] => WP_Post Object
                        (
                            [ID] => 1245
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:32:14
                            [post_date_gmt] => 2020-05-22 21:32:14
                            [post_content] => 
                            [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2-joint-undertaking-model-consortium-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 15:54:36
                            [post_modified_gmt] => 2024-09-19 15:54:36
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1245
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [220] => WP_Post Object
                        (
                            [ID] => 1243
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:29:10
                            [post_date_gmt] => 2020-05-22 21:29:10
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-iia-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:56:09
                            [post_modified_gmt] => 2023-06-20 09:56:09
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1243
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [221] => WP_Post Object
                        (
                            [ID] => 1242
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:26:04
                            [post_date_gmt] => 2020-05-22 21:26:04
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:49:55
                            [post_modified_gmt] => 2024-09-20 07:49:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1242
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [222] => WP_Post Object
                        (
                            [ID] => 1240
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:22:47
                            [post_date_gmt] => 2020-05-22 21:22:47
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:26:42
                            [post_modified_gmt] => 2024-09-23 10:26:42
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1240
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [223] => WP_Post Object
                        (
                            [ID] => 1239
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:21:49
                            [post_date_gmt] => 2020-05-22 21:21:49
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:08:51
                            [post_modified_gmt] => 2024-09-20 07:08:51
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1239
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [224] => WP_Post Object
                        (
                            [ID] => 1238
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:20:51
                            [post_date_gmt] => 2020-05-22 21:20:51
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement-5
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:45:19
                            [post_modified_gmt] => 2023-06-21 07:45:19
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1238
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [225] => WP_Post Object
                        (
                            [ID] => 1237
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:19:08
                            [post_date_gmt] => 2020-05-22 21:19:08
                            [post_content] => 
                            [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2-joint-undertaking-model-consortium-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 15:55:21
                            [post_modified_gmt] => 2024-09-19 15:55:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1237
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [226] => WP_Post Object
                        (
                            [ID] => 1235
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:01:14
                            [post_date_gmt] => 2020-05-22 21:01:14
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:52:08
                            [post_modified_gmt] => 2024-09-20 07:52:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1235
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [227] => WP_Post Object
                        (
                            [ID] => 1233
                            [post_author] => 6
                            [post_date] => 2020-05-22 21:00:08
                            [post_date_gmt] => 2020-05-22 21:00:08
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:44:08
                            [post_modified_gmt] => 2023-06-21 07:44:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1233
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [228] => WP_Post Object
                        (
                            [ID] => 1227
                            [post_author] => 6
                            [post_date] => 2020-05-22 20:48:27
                            [post_date_gmt] => 2020-05-22 20:48:27
                            [post_content] => 
                            [post_title] => WHO – Manufacturer, Ebola Products Collaboration LOA Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ebola-who-manufacturer-loa-annex
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-13 12:56:58
                            [post_modified_gmt] => 2022-10-13 12:56:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1227
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [229] => WP_Post Object
                        (
                            [ID] => 1226
                            [post_author] => 6
                            [post_date] => 2020-05-22 20:47:05
                            [post_date_gmt] => 2020-05-22 20:47:05
                            [post_content] => 
                            [post_title] => WHO Template Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => who-template-material-transfer-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-30 15:08:03
                            [post_modified_gmt] => 2024-10-30 15:08:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1226
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [230] => WP_Post Object
                        (
                            [ID] => 1220
                            [post_author] => 6
                            [post_date] => 2020-05-22 20:05:59
                            [post_date_gmt] => 2020-05-22 20:05:59
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-28 12:59:18
                            [post_modified_gmt] => 2024-10-28 12:59:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1220
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [231] => WP_Post Object
                        (
                            [ID] => 1214
                            [post_author] => 6
                            [post_date] => 2020-05-22 19:55:41
                            [post_date_gmt] => 2020-05-22 19:55:41
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:16:49
                            [post_modified_gmt] => 2024-09-20 07:16:49
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1214
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [232] => WP_Post Object
                        (
                            [ID] => 1190
                            [post_author] => 6
                            [post_date] => 2020-05-22 01:59:48
                            [post_date_gmt] => 2020-05-22 01:59:48
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:24:04
                            [post_modified_gmt] => 2024-09-23 10:24:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1190
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [233] => WP_Post Object
                        (
                            [ID] => 1185
                            [post_author] => 6
                            [post_date] => 2020-05-22 00:10:01
                            [post_date_gmt] => 2020-05-22 00:10:01
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2021-08-20 12:45:45
                            [post_modified_gmt] => 2021-08-20 12:45:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1185
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [234] => WP_Post Object
                        (
                            [ID] => 1182
                            [post_author] => 6
                            [post_date] => 2020-05-22 00:02:42
                            [post_date_gmt] => 2020-05-22 00:02:42
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-iia-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 09:58:52
                            [post_modified_gmt] => 2023-06-20 09:58:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1182
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [235] => WP_Post Object
                        (
                            [ID] => 1177
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:53:56
                            [post_date_gmt] => 2020-05-21 23:53:56
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:18:46
                            [post_modified_gmt] => 2024-09-20 07:18:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1177
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [236] => WP_Post Object
                        (
                            [ID] => 1176
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:52:12
                            [post_date_gmt] => 2020-05-21 23:52:12
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-17 10:30:44
                            [post_modified_gmt] => 2023-10-17 10:30:44
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1176
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [237] => WP_Post Object
                        (
                            [ID] => 1166
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:26:07
                            [post_date_gmt] => 2020-05-21 23:26:07
                            [post_content] => 
                            [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => imi-2-joint-undertaking-model-consortium-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 15:59:37
                            [post_modified_gmt] => 2024-09-19 15:59:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1166
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [238] => WP_Post Object
                        (
                            [ID] => 1164
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:22:37
                            [post_date_gmt] => 2020-05-21 23:22:37
                            [post_content] => 
                            [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => autm-model-iia
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 10:10:29
                            [post_modified_gmt] => 2023-06-20 10:10:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1164
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [239] => WP_Post Object
                        (
                            [ID] => 1160
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:18:03
                            [post_date_gmt] => 2020-05-21 23:18:03
                            [post_content] => 
                            [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => aridis-path-vaccine-formulation-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 10:32:40
                            [post_modified_gmt] => 2024-09-23 10:32:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1160
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [240] => WP_Post Object
                        (
                            [ID] => 1155
                            [post_author] => 6
                            [post_date] => 2020-05-21 23:09:39
                            [post_date_gmt] => 2020-05-21 23:09:39
                            [post_content] => 
                            [post_title] => WHO Template Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => template-collaboration-agreement-with-who
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-30 15:08:39
                            [post_modified_gmt] => 2024-10-30 15:08:39
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1155
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [241] => WP_Post Object
                        (
                            [ID] => 1150
                            [post_author] => 6
                            [post_date] => 2020-05-21 22:53:25
                            [post_date_gmt] => 2020-05-21 22:53:25
                            [post_content] => 
                            [post_title] => Academic Institution - Company, Research Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => redacted-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 07:47:20
                            [post_modified_gmt] => 2023-06-21 07:47:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1150
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [242] => WP_Post Object
                        (
                            [ID] => 1140
                            [post_author] => 6
                            [post_date] => 2020-05-21 22:37:27
                            [post_date_gmt] => 2020-05-21 22:37:27
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 08:06:11
                            [post_modified_gmt] => 2024-09-20 08:06:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1140
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [243] => WP_Post Object
                        (
                            [ID] => 1112
                            [post_author] => 6
                            [post_date] => 2020-05-21 21:06:05
                            [post_date_gmt] => 2020-05-21 21:06:05
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-07 13:05:43
                            [post_modified_gmt] => 2024-11-07 13:05:43
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1112
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [244] => WP_Post Object
                        (
                            [ID] => 1107
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:57:25
                            [post_date_gmt] => 2020-05-21 20:57:25
                            [post_content] => 
                            [post_title] => Lambert Toolkit, Consortium Agreement D Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => lambert-agreement-d
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 07:20:02
                            [post_modified_gmt] => 2024-09-20 07:20:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1107
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                )

            [post_count] => 245
            [current_post] => -1
            [before_loop] => 1
            [in_the_loop] => 
            [post] => WP_Post Object
                (
                    [ID] => 12500
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:35:20
                    [post_date_gmt] => 2025-01-09 15:35:20
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 15:35:20
                    [post_modified_gmt] => 2025-01-09 15:35:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12500
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [comment_count] => 0
            [current_comment] => -1
            [found_posts] => 245
            [max_num_pages] => 0
            [max_num_comment_pages] => 0
            [is_single] => 
            [is_preview] => 
            [is_page] => 
            [is_archive] => 1
            [is_date] => 
            [is_year] => 
            [is_month] => 
            [is_day] => 
            [is_time] => 
            [is_author] => 
            [is_category] => 
            [is_tag] => 
            [is_tax] => 
            [is_search] => 
            [is_feed] => 
            [is_comment_feed] => 
            [is_trackback] => 
            [is_home] => 
            [is_privacy_policy] => 
            [is_404] => 
            [is_embed] => 
            [is_paged] => 
            [is_admin] => 
            [is_attachment] => 
            [is_singular] => 
            [is_robots] => 
            [is_favicon] => 
            [is_posts_page] => 
            [is_post_type_archive] => 1
            [query_vars_hash:WP_Query:private] => fab698437c10953d792b66167f9b2206
            [query_vars_changed:WP_Query:private] => 
            [thumbnails_cached] => 
            [allow_query_attachment_by_filename:protected] => 
            [stopwords:WP_Query:private] => 
            [compat_fields:WP_Query:private] => Array
                (
                    [0] => query_vars_hash
                    [1] => query_vars_changed
                )

            [compat_methods:WP_Query:private] => Array
                (
                    [0] => init_query_flags
                    [1] => parse_tax_query
                )

        )

    [text_agreement_q_rslts] => 
    [text_provision_q_rslts] => 
    [provisions] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 12500
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:35:20
                    [post_date_gmt] => 2025-01-09 15:35:20
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 15:35:20
                    [post_modified_gmt] => 2025-01-09 15:35:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12500
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [1] => WP_Post Object
                (
                    [ID] => 12499
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:31:52
                    [post_date_gmt] => 2025-01-09 15:31:52
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 16:08:52
                    [post_modified_gmt] => 2025-01-09 16:08:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12499
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [2] => WP_Post Object
                (
                    [ID] => 12498
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:12:41
                    [post_date_gmt] => 2025-01-09 15:12:41
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 15:32:14
                    [post_modified_gmt] => 2025-01-09 15:32:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12498
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [3] => WP_Post Object
                (
                    [ID] => 12497
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:09:11
                    [post_date_gmt] => 2025-01-09 15:09:11
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-14 15:02:50
                    [post_modified_gmt] => 2025-01-14 15:02:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12497
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [4] => WP_Post Object
                (
                    [ID] => 12496
                    [post_author] => 5
                    [post_date] => 2025-01-09 15:03:22
                    [post_date_gmt] => 2025-01-09 15:03:22
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 15:03:22
                    [post_modified_gmt] => 2025-01-09 15:03:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12496
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [5] => WP_Post Object
                (
                    [ID] => 12495
                    [post_author] => 5
                    [post_date] => 2025-01-09 12:04:44
                    [post_date_gmt] => 2025-01-09 12:04:44
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-14 14:00:29
                    [post_modified_gmt] => 2025-01-14 14:00:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12495
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [6] => WP_Post Object
                (
                    [ID] => 12494
                    [post_author] => 5
                    [post_date] => 2025-01-09 11:31:20
                    [post_date_gmt] => 2025-01-09 11:31:20
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-14 14:43:26
                    [post_modified_gmt] => 2025-01-14 14:43:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12494
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [7] => WP_Post Object
                (
                    [ID] => 12493
                    [post_author] => 5
                    [post_date] => 2025-01-09 11:05:04
                    [post_date_gmt] => 2025-01-09 11:05:04
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 11:05:04
                    [post_modified_gmt] => 2025-01-09 11:05:04
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12493
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [8] => WP_Post Object
                (
                    [ID] => 12492
                    [post_author] => 5
                    [post_date] => 2025-01-09 09:40:33
                    [post_date_gmt] => 2025-01-09 09:40:33
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-10 11:06:22
                    [post_modified_gmt] => 2025-01-10 11:06:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12492
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [9] => WP_Post Object
                (
                    [ID] => 12491
                    [post_author] => 5
                    [post_date] => 2025-01-09 09:29:05
                    [post_date_gmt] => 2025-01-09 09:29:05
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-14 14:44:45
                    [post_modified_gmt] => 2025-01-14 14:44:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12491
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [10] => WP_Post Object
                (
                    [ID] => 12490
                    [post_author] => 5
                    [post_date] => 2025-01-09 09:24:22
                    [post_date_gmt] => 2025-01-09 09:24:22
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 09:24:22
                    [post_modified_gmt] => 2025-01-09 09:24:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12490
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [11] => WP_Post Object
                (
                    [ID] => 12488
                    [post_author] => 5
                    [post_date] => 2025-01-09 08:50:08
                    [post_date_gmt] => 2025-01-09 08:50:08
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 08:50:08
                    [post_modified_gmt] => 2025-01-09 08:50:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12488
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [12] => WP_Post Object
                (
                    [ID] => 12486
                    [post_author] => 5
                    [post_date] => 2025-01-09 08:50:03
                    [post_date_gmt] => 2025-01-09 08:50:03
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 08:50:03
                    [post_modified_gmt] => 2025-01-09 08:50:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12486
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [13] => WP_Post Object
                (
                    [ID] => 12489
                    [post_author] => 5
                    [post_date] => 2025-01-09 08:49:47
                    [post_date_gmt] => 2025-01-09 08:49:47
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 08:49:47
                    [post_modified_gmt] => 2025-01-09 08:49:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12489
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [14] => WP_Post Object
                (
                    [ID] => 12485
                    [post_author] => 5
                    [post_date] => 2025-01-08 15:46:44
                    [post_date_gmt] => 2025-01-08 15:46:44
                    [post_content] => 
                    [post_title] => IAVI - Theraclone Sciences, HIV Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => iavi-theraclone-sciences-hiv-research-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-09 08:49:58
                    [post_modified_gmt] => 2025-01-09 08:49:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12485
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [15] => WP_Post Object
                (
                    [ID] => 12461
                    [post_author] => 5
                    [post_date] => 2024-12-17 14:50:55
                    [post_date_gmt] => 2024-12-17 14:50:55
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 14:59:52
                    [post_modified_gmt] => 2024-12-17 14:59:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12461
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [16] => WP_Post Object
                (
                    [ID] => 12460
                    [post_author] => 5
                    [post_date] => 2024-12-17 14:23:56
                    [post_date_gmt] => 2024-12-17 14:23:56
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:00:07
                    [post_modified_gmt] => 2024-12-17 15:00:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12460
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [17] => WP_Post Object
                (
                    [ID] => 12459
                    [post_author] => 5
                    [post_date] => 2024-12-17 13:51:05
                    [post_date_gmt] => 2024-12-17 13:51:05
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:00:21
                    [post_modified_gmt] => 2024-12-17 15:00:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12459
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [18] => WP_Post Object
                (
                    [ID] => 12458
                    [post_author] => 5
                    [post_date] => 2024-12-17 13:36:17
                    [post_date_gmt] => 2024-12-17 13:36:17
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:00:32
                    [post_modified_gmt] => 2024-12-17 15:00:32
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12458
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [19] => WP_Post Object
                (
                    [ID] => 12457
                    [post_author] => 5
                    [post_date] => 2024-12-17 13:25:38
                    [post_date_gmt] => 2024-12-17 13:25:38
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:00:46
                    [post_modified_gmt] => 2024-12-17 15:00:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12457
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [20] => WP_Post Object
                (
                    [ID] => 12456
                    [post_author] => 5
                    [post_date] => 2024-12-17 13:14:52
                    [post_date_gmt] => 2024-12-17 13:14:52
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:00:59
                    [post_modified_gmt] => 2024-12-17 15:00:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12456
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [21] => WP_Post Object
                (
                    [ID] => 12455
                    [post_author] => 5
                    [post_date] => 2024-12-17 13:07:14
                    [post_date_gmt] => 2024-12-17 13:07:14
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:01:12
                    [post_modified_gmt] => 2024-12-17 15:01:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12455
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [22] => WP_Post Object
                (
                    [ID] => 12447
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:44:05
                    [post_date_gmt] => 2024-12-17 12:44:05
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:01:28
                    [post_modified_gmt] => 2024-12-17 15:01:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12447
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [23] => WP_Post Object
                (
                    [ID] => 12449
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:42:52
                    [post_date_gmt] => 2024-12-17 12:42:52
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:01:44
                    [post_modified_gmt] => 2024-12-17 15:01:44
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12449
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [24] => WP_Post Object
                (
                    [ID] => 12450
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:40:48
                    [post_date_gmt] => 2024-12-17 12:40:48
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 14:59:36
                    [post_modified_gmt] => 2024-12-17 14:59:36
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12450
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [25] => WP_Post Object
                (
                    [ID] => 12448
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:39:24
                    [post_date_gmt] => 2024-12-17 12:39:24
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:01:57
                    [post_modified_gmt] => 2024-12-17 15:01:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12448
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [26] => WP_Post Object
                (
                    [ID] => 12451
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:38:26
                    [post_date_gmt] => 2024-12-17 12:38:26
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:02:09
                    [post_modified_gmt] => 2024-12-17 15:02:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12451
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [27] => WP_Post Object
                (
                    [ID] => 12452
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:36:37
                    [post_date_gmt] => 2024-12-17 12:36:37
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:02:22
                    [post_modified_gmt] => 2024-12-17 15:02:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12452
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [28] => WP_Post Object
                (
                    [ID] => 12453
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:35:36
                    [post_date_gmt] => 2024-12-17 12:35:36
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:02:34
                    [post_modified_gmt] => 2024-12-17 15:02:34
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12453
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [29] => WP_Post Object
                (
                    [ID] => 12454
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:34:26
                    [post_date_gmt] => 2024-12-17 12:34:26
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:02:46
                    [post_modified_gmt] => 2024-12-17 15:02:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12454
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [30] => WP_Post Object
                (
                    [ID] => 12446
                    [post_author] => 5
                    [post_date] => 2024-12-17 12:29:26
                    [post_date_gmt] => 2024-12-17 12:29:26
                    [post_content] => 
                    [post_title] => Public Health England, Model Fast Track Testing & Evaluation Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-england-model-fast-track-testing-evaluation-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-17 15:02:57
                    [post_modified_gmt] => 2024-12-17 15:02:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12446
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [31] => WP_Post Object
                (
                    [ID] => 12443
                    [post_author] => 5
                    [post_date] => 2024-12-10 10:18:56
                    [post_date_gmt] => 2024-12-10 10:18:56
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-18
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 10:23:40
                    [post_modified_gmt] => 2024-12-10 10:23:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12443
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [32] => WP_Post Object
                (
                    [ID] => 12442
                    [post_author] => 5
                    [post_date] => 2024-12-10 09:35:15
                    [post_date_gmt] => 2024-12-10 09:35:15
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:15:14
                    [post_modified_gmt] => 2024-12-10 13:15:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12442
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [33] => WP_Post Object
                (
                    [ID] => 12440
                    [post_author] => 5
                    [post_date] => 2024-12-09 16:31:10
                    [post_date_gmt] => 2024-12-09 16:31:10
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:14:27
                    [post_modified_gmt] => 2024-12-10 13:14:27
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12440
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [34] => WP_Post Object
                (
                    [ID] => 12439
                    [post_author] => 5
                    [post_date] => 2024-12-09 16:21:25
                    [post_date_gmt] => 2024-12-09 16:21:25
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-09 16:22:45
                    [post_modified_gmt] => 2024-12-09 16:22:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12439
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [35] => WP_Post Object
                (
                    [ID] => 12438
                    [post_author] => 5
                    [post_date] => 2024-12-09 16:01:28
                    [post_date_gmt] => 2024-12-09 16:01:28
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:12:57
                    [post_modified_gmt] => 2024-12-10 13:12:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12438
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [36] => WP_Post Object
                (
                    [ID] => 12437
                    [post_author] => 5
                    [post_date] => 2024-12-09 15:45:57
                    [post_date_gmt] => 2024-12-09 15:45:57
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:11:57
                    [post_modified_gmt] => 2024-12-10 13:11:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12437
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [37] => WP_Post Object
                (
                    [ID] => 12435
                    [post_author] => 5
                    [post_date] => 2024-12-06 15:44:34
                    [post_date_gmt] => 2024-12-06 15:44:34
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 11:05:05
                    [post_modified_gmt] => 2024-12-10 11:05:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12435
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [38] => WP_Post Object
                (
                    [ID] => 12434
                    [post_author] => 5
                    [post_date] => 2024-12-06 13:51:26
                    [post_date_gmt] => 2024-12-06 13:51:26
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 11:23:13
                    [post_modified_gmt] => 2024-12-10 11:23:13
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12434
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [39] => WP_Post Object
                (
                    [ID] => 12433
                    [post_author] => 5
                    [post_date] => 2024-12-06 12:53:03
                    [post_date_gmt] => 2024-12-06 12:53:03
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-06 13:00:18
                    [post_modified_gmt] => 2024-12-06 13:00:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12433
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [40] => WP_Post Object
                (
                    [ID] => 12432
                    [post_author] => 5
                    [post_date] => 2024-12-06 12:48:15
                    [post_date_gmt] => 2024-12-06 12:48:15
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:03:28
                    [post_modified_gmt] => 2024-12-10 13:03:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12432
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [41] => WP_Post Object
                (
                    [ID] => 12431
                    [post_author] => 5
                    [post_date] => 2024-12-06 12:26:39
                    [post_date_gmt] => 2024-12-06 12:26:39
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 12:59:35
                    [post_modified_gmt] => 2024-12-10 12:59:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12431
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [42] => WP_Post Object
                (
                    [ID] => 12430
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:59:58
                    [post_date_gmt] => 2024-12-06 11:59:58
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-06 11:59:58
                    [post_modified_gmt] => 2024-12-06 11:59:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12430
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [43] => WP_Post Object
                (
                    [ID] => 12429
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:54:11
                    [post_date_gmt] => 2024-12-06 11:54:11
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 12:55:20
                    [post_modified_gmt] => 2024-12-10 12:55:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12429
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [44] => WP_Post Object
                (
                    [ID] => 12428
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:53:23
                    [post_date_gmt] => 2024-12-06 11:53:23
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 10:44:05
                    [post_modified_gmt] => 2024-12-10 10:44:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12428
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [45] => WP_Post Object
                (
                    [ID] => 12427
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:53:07
                    [post_date_gmt] => 2024-12-06 11:53:07
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 10:42:12
                    [post_modified_gmt] => 2024-12-10 10:42:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12427
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [46] => WP_Post Object
                (
                    [ID] => 12426
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:52:52
                    [post_date_gmt] => 2024-12-06 11:52:52
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:10:45
                    [post_modified_gmt] => 2024-12-10 13:10:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12426
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [47] => WP_Post Object
                (
                    [ID] => 12425
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:52:08
                    [post_date_gmt] => 2024-12-06 11:52:08
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:05:12
                    [post_modified_gmt] => 2024-12-10 13:05:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12425
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [48] => WP_Post Object
                (
                    [ID] => 12424
                    [post_author] => 5
                    [post_date] => 2024-12-06 11:52:02
                    [post_date_gmt] => 2024-12-06 11:52:02
                    [post_content] => 
                    [post_title] => Roche - PTC Therapeutics - Spinal Muscular Atrophy Foundation, SMA Therapeutic License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => roche-ptc-therapeutics-spinal-muscular-atrophy-foundation-sma-therapeutic-license-and-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-10 13:06:33
                    [post_modified_gmt] => 2024-12-10 13:06:33
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12424
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [49] => WP_Post Object
                (
                    [ID] => 12397
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:58:17
                    [post_date_gmt] => 2024-12-02 16:58:17
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:59:29
                    [post_modified_gmt] => 2024-12-02 16:59:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12397
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [50] => WP_Post Object
                (
                    [ID] => 12110
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:57:40
                    [post_date_gmt] => 2024-12-02 16:57:40
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:57:40
                    [post_modified_gmt] => 2024-12-02 16:57:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12110
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [51] => WP_Post Object
                (
                    [ID] => 12112
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:57:07
                    [post_date_gmt] => 2024-12-02 16:57:07
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:57:07
                    [post_modified_gmt] => 2024-12-02 16:57:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12112
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [52] => WP_Post Object
                (
                    [ID] => 12111
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:56:26
                    [post_date_gmt] => 2024-12-02 16:56:26
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:56:26
                    [post_modified_gmt] => 2024-12-02 16:56:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12111
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [53] => WP_Post Object
                (
                    [ID] => 12394
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:52:54
                    [post_date_gmt] => 2024-12-02 16:52:54
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:54:09
                    [post_modified_gmt] => 2024-12-02 16:54:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12394
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [54] => WP_Post Object
                (
                    [ID] => 12398
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:51:33
                    [post_date_gmt] => 2024-12-02 16:51:33
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:51:33
                    [post_modified_gmt] => 2024-12-02 16:51:33
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12398
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [55] => WP_Post Object
                (
                    [ID] => 12399
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:50:37
                    [post_date_gmt] => 2024-12-02 16:50:37
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:50:37
                    [post_modified_gmt] => 2024-12-02 16:50:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12399
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [56] => WP_Post Object
                (
                    [ID] => 12400
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:50:09
                    [post_date_gmt] => 2024-12-02 16:50:09
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:50:09
                    [post_modified_gmt] => 2024-12-02 16:50:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12400
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [57] => WP_Post Object
                (
                    [ID] => 12404
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:45:25
                    [post_date_gmt] => 2024-12-02 16:45:25
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:45:25
                    [post_modified_gmt] => 2024-12-02 16:45:25
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12404
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [58] => WP_Post Object
                (
                    [ID] => 12396
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:33:33
                    [post_date_gmt] => 2024-12-02 16:33:33
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-06 16:04:07
                    [post_modified_gmt] => 2024-12-06 16:04:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12396
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [59] => WP_Post Object
                (
                    [ID] => 12384
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:30:03
                    [post_date_gmt] => 2024-12-02 16:30:03
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:30:03
                    [post_modified_gmt] => 2024-12-02 16:30:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12384
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [60] => WP_Post Object
                (
                    [ID] => 12114
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:26:14
                    [post_date_gmt] => 2024-12-02 16:26:14
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:26:14
                    [post_modified_gmt] => 2024-12-02 16:26:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12114
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [61] => WP_Post Object
                (
                    [ID] => 12113
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:23:50
                    [post_date_gmt] => 2024-12-02 16:23:50
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:35:16
                    [post_modified_gmt] => 2024-12-02 16:35:16
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12113
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [62] => WP_Post Object
                (
                    [ID] => 12395
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:15:41
                    [post_date_gmt] => 2024-12-02 16:15:41
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-06 15:28:17
                    [post_modified_gmt] => 2024-12-06 15:28:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12395
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [63] => WP_Post Object
                (
                    [ID] => 12401
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:11:01
                    [post_date_gmt] => 2024-12-02 16:11:01
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:54:41
                    [post_modified_gmt] => 2024-12-02 16:54:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12401
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [64] => WP_Post Object
                (
                    [ID] => 12393
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:07:52
                    [post_date_gmt] => 2024-12-02 16:07:52
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:34:17
                    [post_modified_gmt] => 2024-12-02 16:34:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12393
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [65] => WP_Post Object
                (
                    [ID] => 12115
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:04:45
                    [post_date_gmt] => 2024-12-02 16:04:45
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-02 16:08:21
                    [post_modified_gmt] => 2024-12-02 16:08:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12115
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [66] => WP_Post Object
                (
                    [ID] => 11584
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:43:47
                    [post_date_gmt] => 2023-12-21 12:43:47
                    [post_content] => 
                    [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-21 12:43:47
                    [post_modified_gmt] => 2023-12-21 12:43:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11584
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [67] => WP_Post Object
                (
                    [ID] => 11583
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:34:00
                    [post_date_gmt] => 2023-12-21 12:34:00
                    [post_content] => 
                    [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-21 12:36:19
                    [post_modified_gmt] => 2023-12-21 12:36:19
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11583
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [68] => WP_Post Object
                (
                    [ID] => 11582
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:31:08
                    [post_date_gmt] => 2023-12-21 12:31:08
                    [post_content] => 
                    [post_title] => UK Medical Research Council – Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 14:03:51
                    [post_modified_gmt] => 2023-12-23 14:03:51
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11582
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [69] => WP_Post Object
                (
                    [ID] => 11578
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:25:49
                    [post_date_gmt] => 2023-12-21 12:25:49
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 13:41:06
                    [post_modified_gmt] => 2023-12-23 13:41:06
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11578
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [70] => WP_Post Object
                (
                    [ID] => 11573
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:24:41
                    [post_date_gmt] => 2023-12-21 12:24:41
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 13:23:19
                    [post_modified_gmt] => 2023-12-23 13:23:19
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11573
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [71] => WP_Post Object
                (
                    [ID] => 11577
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:24:14
                    [post_date_gmt] => 2023-12-21 12:24:14
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 13:44:52
                    [post_modified_gmt] => 2023-12-23 13:44:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11577
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [72] => WP_Post Object
                (
                    [ID] => 11576
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:23:34
                    [post_date_gmt] => 2023-12-21 12:23:34
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-04 07:46:18
                    [post_modified_gmt] => 2024-09-04 07:46:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11576
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [73] => WP_Post Object
                (
                    [ID] => 11575
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:22:39
                    [post_date_gmt] => 2023-12-21 12:22:39
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-21 12:22:39
                    [post_modified_gmt] => 2023-12-21 12:22:39
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11575
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [74] => WP_Post Object
                (
                    [ID] => 11574
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:21:54
                    [post_date_gmt] => 2023-12-21 12:21:54
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 13:46:59
                    [post_modified_gmt] => 2023-12-23 13:46:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11574
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [75] => WP_Post Object
                (
                    [ID] => 11572
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:21:17
                    [post_date_gmt] => 2023-12-21 12:21:17
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 13:59:48
                    [post_modified_gmt] => 2023-12-23 13:59:48
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11572
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [76] => WP_Post Object
                (
                    [ID] => 11570
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:20:51
                    [post_date_gmt] => 2023-12-21 12:20:51
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 14:01:12
                    [post_modified_gmt] => 2023-12-23 14:01:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11570
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [77] => WP_Post Object
                (
                    [ID] => 11581
                    [post_author] => 5
                    [post_date] => 2023-12-21 12:18:22
                    [post_date_gmt] => 2023-12-21 12:18:22
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-23 14:02:18
                    [post_modified_gmt] => 2023-12-23 14:02:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11581
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [78] => WP_Post Object
                (
                    [ID] => 11580
                    [post_author] => 5
                    [post_date] => 2023-12-21 11:59:11
                    [post_date_gmt] => 2023-12-21 11:59:11
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-04 10:54:52
                    [post_modified_gmt] => 2024-09-04 10:54:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11580
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [79] => WP_Post Object
                (
                    [ID] => 11579
                    [post_author] => 5
                    [post_date] => 2023-12-21 11:09:11
                    [post_date_gmt] => 2023-12-21 11:09:11
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-21 11:09:55
                    [post_modified_gmt] => 2023-12-21 11:09:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11579
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [80] => WP_Post Object
                (
                    [ID] => 9894
                    [post_author] => 5
                    [post_date] => 2023-04-20 12:27:42
                    [post_date_gmt] => 2023-04-20 12:27:42
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-19
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-05 15:00:14
                    [post_modified_gmt] => 2023-06-05 15:00:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9894
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [81] => WP_Post Object
                (
                    [ID] => 9893
                    [post_author] => 5
                    [post_date] => 2023-04-20 12:20:05
                    [post_date_gmt] => 2023-04-20 12:20:05
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-18
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 11:43:45
                    [post_modified_gmt] => 2023-06-27 11:43:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9893
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [82] => WP_Post Object
                (
                    [ID] => 9892
                    [post_author] => 5
                    [post_date] => 2023-04-20 12:00:13
                    [post_date_gmt] => 2023-04-20 12:00:13
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 09:25:45
                    [post_modified_gmt] => 2024-01-11 09:25:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9892
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [83] => WP_Post Object
                (
                    [ID] => 9891
                    [post_author] => 5
                    [post_date] => 2023-04-20 08:44:23
                    [post_date_gmt] => 2023-04-20 08:44:23
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:41:12
                    [post_modified_gmt] => 2023-06-27 13:41:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9891
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [84] => WP_Post Object
                (
                    [ID] => 9890
                    [post_author] => 5
                    [post_date] => 2023-04-20 08:28:58
                    [post_date_gmt] => 2023-04-20 08:28:58
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:39:29
                    [post_modified_gmt] => 2023-06-27 13:39:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9890
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [85] => WP_Post Object
                (
                    [ID] => 9889
                    [post_author] => 5
                    [post_date] => 2023-04-20 08:26:21
                    [post_date_gmt] => 2023-04-20 08:26:21
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:27:42
                    [post_modified_gmt] => 2023-06-27 13:27:42
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9889
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [86] => WP_Post Object
                (
                    [ID] => 9888
                    [post_author] => 5
                    [post_date] => 2023-04-20 08:15:26
                    [post_date_gmt] => 2023-04-20 08:15:26
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:20:51
                    [post_modified_gmt] => 2023-06-27 13:20:51
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9888
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [87] => WP_Post Object
                (
                    [ID] => 9886
                    [post_author] => 5
                    [post_date] => 2023-04-20 08:00:35
                    [post_date_gmt] => 2023-04-20 08:00:35
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:15:10
                    [post_modified_gmt] => 2023-06-27 13:15:10
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9886
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [88] => WP_Post Object
                (
                    [ID] => 9885
                    [post_author] => 5
                    [post_date] => 2023-04-19 15:03:20
                    [post_date_gmt] => 2023-04-19 15:03:20
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 09:26:02
                    [post_modified_gmt] => 2024-01-11 09:26:02
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9885
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [89] => WP_Post Object
                (
                    [ID] => 9884
                    [post_author] => 5
                    [post_date] => 2023-04-19 14:28:15
                    [post_date_gmt] => 2023-04-19 14:28:15
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 08:21:50
                    [post_modified_gmt] => 2023-10-17 08:21:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9884
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [90] => WP_Post Object
                (
                    [ID] => 9883
                    [post_author] => 5
                    [post_date] => 2023-04-19 13:59:07
                    [post_date_gmt] => 2023-04-19 13:59:07
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 08:19:57
                    [post_modified_gmt] => 2023-10-17 08:19:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9883
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [91] => WP_Post Object
                (
                    [ID] => 9882
                    [post_author] => 5
                    [post_date] => 2023-04-19 13:38:50
                    [post_date_gmt] => 2023-04-19 13:38:50
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:12:35
                    [post_modified_gmt] => 2023-06-27 13:12:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9882
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [92] => WP_Post Object
                (
                    [ID] => 9881
                    [post_author] => 5
                    [post_date] => 2023-04-19 13:28:03
                    [post_date_gmt] => 2023-04-19 13:28:03
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:29:59
                    [post_modified_gmt] => 2023-06-27 13:29:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9881
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [93] => WP_Post Object
                (
                    [ID] => 9880
                    [post_author] => 5
                    [post_date] => 2023-04-19 13:15:50
                    [post_date_gmt] => 2023-04-19 13:15:50
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 11:54:53
                    [post_modified_gmt] => 2023-06-27 11:54:53
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9880
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [94] => WP_Post Object
                (
                    [ID] => 9879
                    [post_author] => 5
                    [post_date] => 2023-04-19 13:00:06
                    [post_date_gmt] => 2023-04-19 13:00:06
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-04 10:49:06
                    [post_modified_gmt] => 2024-09-04 10:49:06
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9879
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [95] => WP_Post Object
                (
                    [ID] => 9877
                    [post_author] => 5
                    [post_date] => 2023-04-19 11:54:25
                    [post_date_gmt] => 2023-04-19 11:54:25
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-10 14:12:20
                    [post_modified_gmt] => 2023-11-10 14:12:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9877
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [96] => WP_Post Object
                (
                    [ID] => 9875
                    [post_author] => 5
                    [post_date] => 2023-04-19 10:41:01
                    [post_date_gmt] => 2023-04-19 10:41:01
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 11:59:40
                    [post_modified_gmt] => 2023-06-27 11:59:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9875
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [97] => WP_Post Object
                (
                    [ID] => 9874
                    [post_author] => 5
                    [post_date] => 2023-04-18 15:17:41
                    [post_date_gmt] => 2023-04-18 15:17:41
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 11:50:00
                    [post_modified_gmt] => 2023-06-27 11:50:00
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9874
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [98] => WP_Post Object
                (
                    [ID] => 9873
                    [post_author] => 5
                    [post_date] => 2023-04-18 14:52:22
                    [post_date_gmt] => 2023-04-18 14:52:22
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-28 12:40:40
                    [post_modified_gmt] => 2024-10-28 12:40:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9873
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [99] => WP_Post Object
                (
                    [ID] => 9872
                    [post_author] => 5
                    [post_date] => 2023-04-18 13:17:39
                    [post_date_gmt] => 2023-04-18 13:17:39
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:24:05
                    [post_modified_gmt] => 2023-06-27 14:24:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9872
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [100] => WP_Post Object
                (
                    [ID] => 9871
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:57:25
                    [post_date_gmt] => 2023-04-18 10:57:25
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:25:17
                    [post_modified_gmt] => 2023-06-27 14:25:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9871
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [101] => WP_Post Object
                (
                    [ID] => 9870
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:46:43
                    [post_date_gmt] => 2023-04-18 10:46:43
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:24:37
                    [post_modified_gmt] => 2023-06-27 14:24:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9870
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [102] => WP_Post Object
                (
                    [ID] => 9869
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:43:52
                    [post_date_gmt] => 2023-04-18 10:43:52
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:19:16
                    [post_modified_gmt] => 2023-06-27 14:19:16
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9869
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [103] => WP_Post Object
                (
                    [ID] => 9868
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:40:41
                    [post_date_gmt] => 2023-04-18 10:40:41
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:20:07
                    [post_modified_gmt] => 2023-06-27 14:20:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9868
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [104] => WP_Post Object
                (
                    [ID] => 9867
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:21:23
                    [post_date_gmt] => 2023-04-18 10:21:23
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:02:27
                    [post_modified_gmt] => 2023-06-27 14:02:27
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9867
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [105] => WP_Post Object
                (
                    [ID] => 9866
                    [post_author] => 5
                    [post_date] => 2023-04-18 10:10:55
                    [post_date_gmt] => 2023-04-18 10:10:55
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:59:41
                    [post_modified_gmt] => 2023-06-27 13:59:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9866
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [106] => WP_Post Object
                (
                    [ID] => 9865
                    [post_author] => 5
                    [post_date] => 2023-04-18 09:13:30
                    [post_date_gmt] => 2023-04-18 09:13:30
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 08:25:18
                    [post_modified_gmt] => 2023-10-17 08:25:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9865
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [107] => WP_Post Object
                (
                    [ID] => 9863
                    [post_author] => 5
                    [post_date] => 2023-04-18 08:21:11
                    [post_date_gmt] => 2023-04-18 08:21:11
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 08:24:50
                    [post_modified_gmt] => 2023-10-17 08:24:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9863
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [108] => WP_Post Object
                (
                    [ID] => 9864
                    [post_author] => 5
                    [post_date] => 2023-04-18 07:54:00
                    [post_date_gmt] => 2023-04-18 07:54:00
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 14:08:29
                    [post_modified_gmt] => 2023-06-27 14:08:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9864
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [109] => WP_Post Object
                (
                    [ID] => 9862
                    [post_author] => 5
                    [post_date] => 2023-04-17 14:28:56
                    [post_date_gmt] => 2023-04-17 14:28:56
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:49:26
                    [post_modified_gmt] => 2023-06-27 13:49:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9862
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [110] => WP_Post Object
                (
                    [ID] => 9861
                    [post_author] => 5
                    [post_date] => 2023-04-17 14:18:47
                    [post_date_gmt] => 2023-04-17 14:18:47
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:48:20
                    [post_modified_gmt] => 2023-06-27 13:48:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9861
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [111] => WP_Post Object
                (
                    [ID] => 9860
                    [post_author] => 5
                    [post_date] => 2023-04-14 14:35:29
                    [post_date_gmt] => 2023-04-14 14:35:29
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-10 14:12:45
                    [post_modified_gmt] => 2023-11-10 14:12:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9860
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [112] => WP_Post Object
                (
                    [ID] => 9859
                    [post_author] => 5
                    [post_date] => 2023-04-14 13:08:09
                    [post_date_gmt] => 2023-04-14 13:08:09
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:45:17
                    [post_modified_gmt] => 2023-06-27 13:45:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9859
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [113] => WP_Post Object
                (
                    [ID] => 6333
                    [post_author] => 5
                    [post_date] => 2022-10-27 15:17:29
                    [post_date_gmt] => 2022-10-27 15:17:29
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:51:02
                    [post_modified_gmt] => 2024-04-08 12:51:02
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6333
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [114] => WP_Post Object
                (
                    [ID] => 6332
                    [post_author] => 5
                    [post_date] => 2022-10-27 15:11:17
                    [post_date_gmt] => 2022-10-27 15:11:17
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:53:01
                    [post_modified_gmt] => 2024-04-08 12:53:01
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6332
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [115] => WP_Post Object
                (
                    [ID] => 6330
                    [post_author] => 5
                    [post_date] => 2022-10-27 15:05:13
                    [post_date_gmt] => 2022-10-27 15:05:13
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:52:22
                    [post_modified_gmt] => 2024-04-08 12:52:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6330
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [116] => WP_Post Object
                (
                    [ID] => 6329
                    [post_author] => 5
                    [post_date] => 2022-10-27 11:59:35
                    [post_date_gmt] => 2022-10-27 11:59:35
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:49:56
                    [post_modified_gmt] => 2024-04-08 12:49:56
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6329
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [117] => WP_Post Object
                (
                    [ID] => 6328
                    [post_author] => 5
                    [post_date] => 2022-10-27 11:49:09
                    [post_date_gmt] => 2022-10-27 11:49:09
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:50:18
                    [post_modified_gmt] => 2024-04-08 12:50:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6328
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [118] => WP_Post Object
                (
                    [ID] => 6327
                    [post_author] => 5
                    [post_date] => 2022-10-27 11:45:45
                    [post_date_gmt] => 2022-10-27 11:45:45
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-20 16:27:41
                    [post_modified_gmt] => 2023-12-20 16:27:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6327
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [119] => WP_Post Object
                (
                    [ID] => 6326
                    [post_author] => 5
                    [post_date] => 2022-10-27 11:13:28
                    [post_date_gmt] => 2022-10-27 11:13:28
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-08-20 15:57:40
                    [post_modified_gmt] => 2024-08-20 15:57:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6326
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [120] => WP_Post Object
                (
                    [ID] => 6325
                    [post_author] => 5
                    [post_date] => 2022-10-27 10:57:10
                    [post_date_gmt] => 2022-10-27 10:57:10
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 15:15:37
                    [post_modified_gmt] => 2023-10-17 15:15:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6325
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [121] => WP_Post Object
                (
                    [ID] => 6324
                    [post_author] => 5
                    [post_date] => 2022-10-27 10:23:50
                    [post_date_gmt] => 2022-10-27 10:23:50
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 15:18:21
                    [post_modified_gmt] => 2023-10-17 15:18:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6324
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [122] => WP_Post Object
                (
                    [ID] => 6323
                    [post_author] => 5
                    [post_date] => 2022-10-27 09:37:11
                    [post_date_gmt] => 2022-10-27 09:37:11
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 15:19:39
                    [post_modified_gmt] => 2023-10-17 15:19:39
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6323
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [123] => WP_Post Object
                (
                    [ID] => 6322
                    [post_author] => 5
                    [post_date] => 2022-10-27 09:13:33
                    [post_date_gmt] => 2022-10-27 09:13:33
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 09:36:54
                    [post_modified_gmt] => 2024-01-11 09:36:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6322
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [124] => WP_Post Object
                (
                    [ID] => 6319
                    [post_author] => 5
                    [post_date] => 2022-10-26 13:16:20
                    [post_date_gmt] => 2022-10-26 13:16:20
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-20 16:18:29
                    [post_modified_gmt] => 2023-12-20 16:18:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6319
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [125] => WP_Post Object
                (
                    [ID] => 6318
                    [post_author] => 5
                    [post_date] => 2022-10-26 13:08:20
                    [post_date_gmt] => 2022-10-26 13:08:20
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 15:21:30
                    [post_modified_gmt] => 2023-10-17 15:21:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6318
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [126] => WP_Post Object
                (
                    [ID] => 6317
                    [post_author] => 5
                    [post_date] => 2022-10-26 12:22:38
                    [post_date_gmt] => 2022-10-26 12:22:38
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-10 14:13:25
                    [post_modified_gmt] => 2023-11-10 14:13:25
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6317
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [127] => WP_Post Object
                (
                    [ID] => 6316
                    [post_author] => 5
                    [post_date] => 2022-10-26 11:26:56
                    [post_date_gmt] => 2022-10-26 11:26:56
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-20 16:22:59
                    [post_modified_gmt] => 2023-12-20 16:22:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6316
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [128] => WP_Post Object
                (
                    [ID] => 6315
                    [post_author] => 5
                    [post_date] => 2022-10-26 10:20:15
                    [post_date_gmt] => 2022-10-26 10:20:15
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-20 16:26:54
                    [post_modified_gmt] => 2023-12-20 16:26:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6315
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [129] => WP_Post Object
                (
                    [ID] => 6314
                    [post_author] => 5
                    [post_date] => 2022-10-26 10:01:08
                    [post_date_gmt] => 2022-10-26 10:01:08
                    [post_content] => 
                    [post_title] => DNDi – BioDelivery Sciences International, Visceral Leishmaniasis Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => drugs-for-neglected-diseases-initiative-biodelivery-sciences-international-visceral-leishmaniasis-research-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-20 16:24:52
                    [post_modified_gmt] => 2023-12-20 16:24:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=6314
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [130] => WP_Post Object
                (
                    [ID] => 5809
                    [post_author] => 5
                    [post_date] => 2022-10-05 07:50:36
                    [post_date_gmt] => 2022-10-05 07:50:36
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:22:58
                    [post_modified_gmt] => 2024-09-23 10:22:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5809
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [131] => WP_Post Object
                (
                    [ID] => 5700
                    [post_author] => 5
                    [post_date] => 2022-09-07 11:00:26
                    [post_date_gmt] => 2022-09-07 11:00:26
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:43:35
                    [post_modified_gmt] => 2023-06-20 09:43:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5700
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [132] => WP_Post Object
                (
                    [ID] => 5699
                    [post_author] => 5
                    [post_date] => 2022-09-07 10:28:24
                    [post_date_gmt] => 2022-09-07 10:28:24
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:47:41
                    [post_modified_gmt] => 2023-06-20 09:47:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5699
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [133] => WP_Post Object
                (
                    [ID] => 5698
                    [post_author] => 5
                    [post_date] => 2022-09-07 10:14:27
                    [post_date_gmt] => 2022-09-07 10:14:27
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:44:42
                    [post_modified_gmt] => 2023-06-20 09:44:42
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5698
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [134] => WP_Post Object
                (
                    [ID] => 5697
                    [post_author] => 5
                    [post_date] => 2022-09-07 10:01:19
                    [post_date_gmt] => 2022-09-07 10:01:19
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 06:47:05
                    [post_modified_gmt] => 2023-06-20 06:47:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5697
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [135] => WP_Post Object
                (
                    [ID] => 5696
                    [post_author] => 5
                    [post_date] => 2022-09-07 09:45:07
                    [post_date_gmt] => 2022-09-07 09:45:07
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 06:39:46
                    [post_modified_gmt] => 2023-06-20 06:39:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5696
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [136] => WP_Post Object
                (
                    [ID] => 5695
                    [post_author] => 5
                    [post_date] => 2022-09-07 09:35:25
                    [post_date_gmt] => 2022-09-07 09:35:25
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 06:33:29
                    [post_modified_gmt] => 2023-06-20 06:33:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5695
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [137] => WP_Post Object
                (
                    [ID] => 5694
                    [post_author] => 5
                    [post_date] => 2022-09-07 09:11:50
                    [post_date_gmt] => 2022-09-07 09:11:50
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:20:43
                    [post_modified_gmt] => 2023-06-19 15:20:43
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5694
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [138] => WP_Post Object
                (
                    [ID] => 5693
                    [post_author] => 5
                    [post_date] => 2022-09-07 08:51:55
                    [post_date_gmt] => 2022-09-07 08:51:55
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:22:50
                    [post_modified_gmt] => 2023-06-19 15:22:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5693
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [139] => WP_Post Object
                (
                    [ID] => 5692
                    [post_author] => 5
                    [post_date] => 2022-09-07 08:21:55
                    [post_date_gmt] => 2022-09-07 08:21:55
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:15:19
                    [post_modified_gmt] => 2023-10-17 10:15:19
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5692
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [140] => WP_Post Object
                (
                    [ID] => 5691
                    [post_author] => 5
                    [post_date] => 2022-09-07 08:12:00
                    [post_date_gmt] => 2022-09-07 08:12:00
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:27:09
                    [post_modified_gmt] => 2023-06-19 15:27:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5691
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [141] => WP_Post Object
                (
                    [ID] => 5690
                    [post_author] => 5
                    [post_date] => 2022-09-06 18:19:25
                    [post_date_gmt] => 2022-09-06 18:19:25
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-09-06 18:19:25
                    [post_modified_gmt] => 2022-09-06 18:19:25
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5690
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [142] => WP_Post Object
                (
                    [ID] => 5689
                    [post_author] => 5
                    [post_date] => 2022-09-06 18:09:28
                    [post_date_gmt] => 2022-09-06 18:09:28
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:24:14
                    [post_modified_gmt] => 2023-06-19 15:24:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5689
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [143] => WP_Post Object
                (
                    [ID] => 5688
                    [post_author] => 5
                    [post_date] => 2022-09-06 13:35:23
                    [post_date_gmt] => 2022-09-06 13:35:23
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:17:59
                    [post_modified_gmt] => 2023-06-19 15:17:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5688
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [144] => WP_Post Object
                (
                    [ID] => 5684
                    [post_author] => 5
                    [post_date] => 2022-09-06 13:25:46
                    [post_date_gmt] => 2022-09-06 13:25:46
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:19:28
                    [post_modified_gmt] => 2023-06-19 15:19:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5684
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [145] => WP_Post Object
                (
                    [ID] => 5683
                    [post_author] => 5
                    [post_date] => 2022-09-06 13:02:35
                    [post_date_gmt] => 2022-09-06 13:02:35
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:18:57
                    [post_modified_gmt] => 2023-10-17 10:18:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5683
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [146] => WP_Post Object
                (
                    [ID] => 5682
                    [post_author] => 5
                    [post_date] => 2022-09-06 12:46:39
                    [post_date_gmt] => 2022-09-06 12:46:39
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 15:34:15
                    [post_modified_gmt] => 2023-06-19 15:34:15
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5682
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [147] => WP_Post Object
                (
                    [ID] => 5681
                    [post_author] => 5
                    [post_date] => 2022-09-06 12:09:51
                    [post_date_gmt] => 2022-09-06 12:09:51
                    [post_content] => 
                    [post_title] => Alnylam Pharmaceuticals - University of British Columbia- AlCana Technology, Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => alnylam-pharmaceuticals-university-of-british-columbia-alcana-technology-sponsored-research-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:16:35
                    [post_modified_gmt] => 2023-10-17 10:16:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5681
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [148] => WP_Post Object
                (
                    [ID] => 5429
                    [post_author] => 5
                    [post_date] => 2022-07-25 06:51:00
                    [post_date_gmt] => 2022-07-25 06:51:00
                    [post_content] => 
                    [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => sanofi-translate-bio-influenza-and-covid-19-vaccine-collaboration-license-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:56:54
                    [post_modified_gmt] => 2024-09-23 10:56:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5429
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [149] => WP_Post Object
                (
                    [ID] => 4894
                    [post_author] => 5
                    [post_date] => 2022-06-08 13:01:48
                    [post_date_gmt] => 2022-06-08 13:01:48
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-06-09 12:23:23
                    [post_modified_gmt] => 2022-06-09 12:23:23
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4894
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [150] => WP_Post Object
                (
                    [ID] => 4893
                    [post_author] => 5
                    [post_date] => 2022-06-08 12:28:46
                    [post_date_gmt] => 2022-06-08 12:28:46
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-04 10:50:20
                    [post_modified_gmt] => 2024-09-04 10:50:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4893
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [151] => WP_Post Object
                (
                    [ID] => 4892
                    [post_author] => 5
                    [post_date] => 2022-06-08 11:21:42
                    [post_date_gmt] => 2022-06-08 11:21:42
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-24 12:58:23
                    [post_modified_gmt] => 2023-11-24 12:58:23
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4892
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [152] => WP_Post Object
                (
                    [ID] => 4891
                    [post_author] => 5
                    [post_date] => 2022-06-08 10:28:17
                    [post_date_gmt] => 2022-06-08 10:28:17
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:33:47
                    [post_modified_gmt] => 2024-01-09 10:33:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4891
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [153] => WP_Post Object
                (
                    [ID] => 4890
                    [post_author] => 5
                    [post_date] => 2022-06-08 10:10:04
                    [post_date_gmt] => 2022-06-08 10:10:04
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:36:54
                    [post_modified_gmt] => 2024-01-09 10:36:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4890
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [154] => WP_Post Object
                (
                    [ID] => 4889
                    [post_author] => 5
                    [post_date] => 2022-06-08 10:04:27
                    [post_date_gmt] => 2022-06-08 10:04:27
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:36:06
                    [post_modified_gmt] => 2024-01-09 10:36:06
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4889
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [155] => WP_Post Object
                (
                    [ID] => 4888
                    [post_author] => 5
                    [post_date] => 2022-06-08 09:09:43
                    [post_date_gmt] => 2022-06-08 09:09:43
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:26:14
                    [post_modified_gmt] => 2024-01-09 10:26:14
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4888
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [156] => WP_Post Object
                (
                    [ID] => 4886
                    [post_author] => 5
                    [post_date] => 2022-06-08 08:43:51
                    [post_date_gmt] => 2022-06-08 08:43:51
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:23:35
                    [post_modified_gmt] => 2024-01-09 10:23:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4886
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [157] => WP_Post Object
                (
                    [ID] => 4885
                    [post_author] => 5
                    [post_date] => 2022-06-08 08:36:01
                    [post_date_gmt] => 2022-06-08 08:36:01
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-09 10:22:26
                    [post_modified_gmt] => 2024-01-09 10:22:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4885
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [158] => WP_Post Object
                (
                    [ID] => 4884
                    [post_author] => 5
                    [post_date] => 2022-06-08 07:54:05
                    [post_date_gmt] => 2022-06-08 07:54:05
                    [post_content] => 
                    [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-06-09 12:24:23
                    [post_modified_gmt] => 2022-06-09 12:24:23
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4884
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [159] => WP_Post Object
                (
                    [ID] => 4883
                    [post_author] => 5
                    [post_date] => 2022-06-08 07:25:31
                    [post_date_gmt] => 2022-06-08 07:25:31
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 10:02:41
                    [post_modified_gmt] => 2024-01-11 10:02:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4883
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [160] => WP_Post Object
                (
                    [ID] => 4882
                    [post_author] => 5
                    [post_date] => 2022-06-08 07:14:04
                    [post_date_gmt] => 2022-06-08 07:14:04
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 10:03:08
                    [post_modified_gmt] => 2024-01-11 10:03:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4882
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [161] => WP_Post Object
                (
                    [ID] => 4881
                    [post_author] => 5
                    [post_date] => 2022-06-07 13:58:33
                    [post_date_gmt] => 2022-06-07 13:58:33
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-06-09 12:25:30
                    [post_modified_gmt] => 2022-06-09 12:25:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4881
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [162] => WP_Post Object
                (
                    [ID] => 4878
                    [post_author] => 5
                    [post_date] => 2022-06-07 13:47:24
                    [post_date_gmt] => 2022-06-07 13:47:24
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-10-12 12:49:28
                    [post_modified_gmt] => 2022-10-12 12:49:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4878
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [163] => WP_Post Object
                (
                    [ID] => 4877
                    [post_author] => 5
                    [post_date] => 2022-06-07 13:22:01
                    [post_date_gmt] => 2022-06-07 13:22:01
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-24 12:56:46
                    [post_modified_gmt] => 2023-11-24 12:56:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4877
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [164] => WP_Post Object
                (
                    [ID] => 4876
                    [post_author] => 5
                    [post_date] => 2022-06-07 13:03:57
                    [post_date_gmt] => 2022-06-07 13:03:57
                    [post_content] => 
                    [post_title] => Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:09:47
                    [post_modified_gmt] => 2023-10-17 10:09:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4876
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [165] => WP_Post Object
                (
                    [ID] => 4875
                    [post_author] => 5
                    [post_date] => 2022-06-07 11:48:34
                    [post_date_gmt] => 2022-06-07 11:48:34
                    [post_content] => 
                    [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhoea-medication-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 09:55:38
                    [post_modified_gmt] => 2023-10-17 09:55:38
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4875
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [166] => WP_Post Object
                (
                    [ID] => 4873
                    [post_author] => 5
                    [post_date] => 2022-06-07 11:31:58
                    [post_date_gmt] => 2022-06-07 11:31:58
                    [post_content] => 
                    [post_title] => Entasis - DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => entasis-dndi-gardp-gonorrhea-medication-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-11 10:03:37
                    [post_modified_gmt] => 2024-01-11 10:03:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4873
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [167] => WP_Post Object
                (
                    [ID] => 4113
                    [post_author] => 5
                    [post_date] => 2022-01-19 09:21:03
                    [post_date_gmt] => 2022-01-19 09:21:03
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-inter-institutional-research-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:57:07
                    [post_modified_gmt] => 2023-06-20 09:57:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4113
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [168] => WP_Post Object
                (
                    [ID] => 4112
                    [post_author] => 5
                    [post_date] => 2022-01-18 14:43:23
                    [post_date_gmt] => 2022-01-18 14:43:23
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-inter-institutional-research-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 10:19:08
                    [post_modified_gmt] => 2023-06-20 10:19:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4112
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [169] => WP_Post Object
                (
                    [ID] => 4105
                    [post_author] => 5
                    [post_date] => 2022-01-18 13:30:40
                    [post_date_gmt] => 2022-01-18 13:30:40
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-inter-institutional-research-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:48:25
                    [post_modified_gmt] => 2023-06-20 09:48:25
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4105
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [170] => WP_Post Object
                (
                    [ID] => 4098
                    [post_author] => 5
                    [post_date] => 2022-01-12 14:27:12
                    [post_date_gmt] => 2022-01-12 14:27:12
                    [post_content] => 
                    [post_title] => Academic Institution – Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-01-12 14:27:12
                    [post_modified_gmt] => 2022-01-12 14:27:12
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4098
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [171] => WP_Post Object
                (
                    [ID] => 4095
                    [post_author] => 5
                    [post_date] => 2022-01-12 13:39:41
                    [post_date_gmt] => 2022-01-12 13:39:41
                    [post_content] => 
                    [post_title] => Academic Institution – Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-16 14:18:59
                    [post_modified_gmt] => 2023-10-16 14:18:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4095
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [172] => WP_Post Object
                (
                    [ID] => 4094
                    [post_author] => 5
                    [post_date] => 2022-01-12 13:19:48
                    [post_date_gmt] => 2022-01-12 13:19:48
                    [post_content] => 
                    [post_title] => Academic Institution – Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:49:13
                    [post_modified_gmt] => 2023-06-21 07:49:13
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4094
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [173] => WP_Post Object
                (
                    [ID] => 4093
                    [post_author] => 5
                    [post_date] => 2022-01-12 13:01:38
                    [post_date_gmt] => 2022-01-12 13:01:38
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:47:57
                    [post_modified_gmt] => 2023-06-21 07:47:57
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4093
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [174] => WP_Post Object
                (
                    [ID] => 4092
                    [post_author] => 5
                    [post_date] => 2022-01-12 12:33:49
                    [post_date_gmt] => 2022-01-12 12:33:49
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:46:13
                    [post_modified_gmt] => 2023-06-21 07:46:13
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4092
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [175] => WP_Post Object
                (
                    [ID] => 4090
                    [post_author] => 5
                    [post_date] => 2022-01-12 11:48:32
                    [post_date_gmt] => 2022-01-12 11:48:32
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => academic-institution-company-research-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:42:34
                    [post_modified_gmt] => 2023-06-21 07:42:34
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4090
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [176] => WP_Post Object
                (
                    [ID] => 4066
                    [post_author] => 5
                    [post_date] => 2022-01-07 11:35:15
                    [post_date_gmt] => 2022-01-07 11:35:15
                    [post_content] => 
                    [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:31:50
                    [post_modified_gmt] => 2024-09-23 10:31:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4066
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [177] => WP_Post Object
                (
                    [ID] => 4065
                    [post_author] => 5
                    [post_date] => 2022-01-07 11:21:06
                    [post_date_gmt] => 2022-01-07 11:21:06
                    [post_content] => 
                    [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:33:48
                    [post_modified_gmt] => 2024-09-23 10:33:48
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4065
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [178] => WP_Post Object
                (
                    [ID] => 4064
                    [post_author] => 5
                    [post_date] => 2022-01-07 10:57:29
                    [post_date_gmt] => 2022-01-07 10:57:29
                    [post_content] => 
                    [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:34:53
                    [post_modified_gmt] => 2024-09-23 10:34:53
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4064
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [179] => WP_Post Object
                (
                    [ID] => 4063
                    [post_author] => 5
                    [post_date] => 2022-01-07 10:34:51
                    [post_date_gmt] => 2022-01-07 10:34:51
                    [post_content] => 
                    [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:25:43
                    [post_modified_gmt] => 2024-09-23 10:25:43
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4063
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [180] => WP_Post Object
                (
                    [ID] => 4062
                    [post_author] => 5
                    [post_date] => 2022-01-07 10:03:12
                    [post_date_gmt] => 2022-01-07 10:03:12
                    [post_content] => 
                    [post_title] => PATH – Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:30:50
                    [post_modified_gmt] => 2024-09-23 10:30:50
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4062
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [181] => WP_Post Object
                (
                    [ID] => 4061
                    [post_author] => 5
                    [post_date] => 2022-01-07 09:46:42
                    [post_date_gmt] => 2022-01-07 09:46:42
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:24:42
                    [post_modified_gmt] => 2024-09-23 10:24:42
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4061
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [182] => WP_Post Object
                (
                    [ID] => 4060
                    [post_author] => 5
                    [post_date] => 2022-01-07 09:40:49
                    [post_date_gmt] => 2022-01-07 09:40:49
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => path-aridis-rotavirus-vaccine-development-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:21:47
                    [post_modified_gmt] => 2023-10-17 10:21:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4060
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [183] => WP_Post Object
                (
                    [ID] => 4024
                    [post_author] => 5
                    [post_date] => 2021-12-15 15:33:17
                    [post_date_gmt] => 2021-12-15 15:33:17
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-22
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:25:41
                    [post_modified_gmt] => 2024-04-08 12:25:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4024
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [184] => WP_Post Object
                (
                    [ID] => 4022
                    [post_author] => 5
                    [post_date] => 2021-12-15 14:49:36
                    [post_date_gmt] => 2021-12-15 14:49:36
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-20
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:45:30
                    [post_modified_gmt] => 2024-04-08 12:45:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4022
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [185] => WP_Post Object
                (
                    [ID] => 4021
                    [post_author] => 5
                    [post_date] => 2021-12-15 14:31:00
                    [post_date_gmt] => 2021-12-15 14:31:00
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-19
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:47:16
                    [post_modified_gmt] => 2024-04-08 12:47:16
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4021
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [186] => WP_Post Object
                (
                    [ID] => 4020
                    [post_author] => 5
                    [post_date] => 2021-12-15 14:24:47
                    [post_date_gmt] => 2021-12-15 14:24:47
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-18
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:46:03
                    [post_modified_gmt] => 2024-04-08 12:46:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4020
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [187] => WP_Post Object
                (
                    [ID] => 4017
                    [post_author] => 5
                    [post_date] => 2021-12-15 13:22:49
                    [post_date_gmt] => 2021-12-15 13:22:49
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:27:29
                    [post_modified_gmt] => 2024-04-08 12:27:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4017
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [188] => WP_Post Object
                (
                    [ID] => 4016
                    [post_author] => 5
                    [post_date] => 2021-12-15 13:20:07
                    [post_date_gmt] => 2021-12-15 13:20:07
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 12:24:47
                    [post_modified_gmt] => 2024-04-08 12:24:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4016
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [189] => WP_Post Object
                (
                    [ID] => 4014
                    [post_author] => 5
                    [post_date] => 2021-12-15 12:33:09
                    [post_date_gmt] => 2021-12-15 12:33:09
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 14:58:11
                    [post_modified_gmt] => 2023-09-27 14:58:11
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4014
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [190] => WP_Post Object
                (
                    [ID] => 4013
                    [post_author] => 5
                    [post_date] => 2021-12-15 12:16:20
                    [post_date_gmt] => 2021-12-15 12:16:20
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 12:14:58
                    [post_modified_gmt] => 2023-09-27 12:14:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4013
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [191] => WP_Post Object
                (
                    [ID] => 4011
                    [post_author] => 5
                    [post_date] => 2021-12-14 15:21:54
                    [post_date_gmt] => 2021-12-14 15:21:54
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 15:31:35
                    [post_modified_gmt] => 2023-09-27 15:31:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4011
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [192] => WP_Post Object
                (
                    [ID] => 4009
                    [post_author] => 5
                    [post_date] => 2021-12-14 15:10:51
                    [post_date_gmt] => 2021-12-14 15:10:51
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-and-gsk-collaboration-and-license-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 11:47:52
                    [post_modified_gmt] => 2023-09-27 11:47:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4009
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [193] => WP_Post Object
                (
                    [ID] => 4007
                    [post_author] => 5
                    [post_date] => 2021-12-14 08:51:32
                    [post_date_gmt] => 2021-12-14 08:51:32
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-04 10:48:30
                    [post_modified_gmt] => 2024-09-04 10:48:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4007
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [194] => WP_Post Object
                (
                    [ID] => 4006
                    [post_author] => 5
                    [post_date] => 2021-12-14 08:16:01
                    [post_date_gmt] => 2021-12-14 08:16:01
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 15:02:09
                    [post_modified_gmt] => 2023-09-27 15:02:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4006
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [195] => WP_Post Object
                (
                    [ID] => 4004
                    [post_author] => 5
                    [post_date] => 2021-12-14 07:57:41
                    [post_date_gmt] => 2021-12-14 07:57:41
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 11:52:42
                    [post_modified_gmt] => 2023-09-27 11:52:42
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4004
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [196] => WP_Post Object
                (
                    [ID] => 4003
                    [post_author] => 5
                    [post_date] => 2021-12-13 18:36:53
                    [post_date_gmt] => 2021-12-13 18:36:53
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 14:52:45
                    [post_modified_gmt] => 2023-09-27 14:52:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4003
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [197] => WP_Post Object
                (
                    [ID] => 4002
                    [post_author] => 5
                    [post_date] => 2021-12-13 18:28:05
                    [post_date_gmt] => 2021-12-13 18:28:05
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-08-20 15:56:24
                    [post_modified_gmt] => 2024-08-20 15:56:24
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4002
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [198] => WP_Post Object
                (
                    [ID] => 4001
                    [post_author] => 5
                    [post_date] => 2021-12-13 14:55:46
                    [post_date_gmt] => 2021-12-13 14:55:46
                    [post_content] => 
                    [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 15:20:07
                    [post_modified_gmt] => 2023-09-27 15:20:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4001
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [199] => WP_Post Object
                (
                    [ID] => 3997
                    [post_author] => 5
                    [post_date] => 2021-12-13 14:24:49
                    [post_date_gmt] => 2021-12-13 14:24:49
                    [post_content] => 
                    [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-gsk-covid-19-vaccine-collaboration-and-license-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 15:35:24
                    [post_modified_gmt] => 2023-09-27 15:35:24
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=3997
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [200] => WP_Post Object
                (
                    [ID] => 3698
                    [post_author] => 5
                    [post_date] => 2021-08-19 14:33:22
                    [post_date_gmt] => 2021-08-19 14:33:22
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-inter-institutional-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:50:03
                    [post_modified_gmt] => 2023-06-20 09:50:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=3698
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [201] => WP_Post Object
                (
                    [ID] => 2972
                    [post_author] => 5
                    [post_date] => 2021-06-01 10:17:19
                    [post_date_gmt] => 2021-06-01 10:17:19
                    [post_content] => 
                    [post_title] => WHO Template Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => who-template-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-01-27 11:59:00
                    [post_modified_gmt] => 2022-01-27 11:59:00
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=2972
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [202] => WP_Post Object
                (
                    [ID] => 2426
                    [post_author] => 5
                    [post_date] => 2020-12-14 15:02:08
                    [post_date_gmt] => 2020-12-14 15:02:08
                    [post_content] => 
                    [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => sanofi-translate-bio-collaboration-and-license-agreement-as-amended-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 11:46:38
                    [post_modified_gmt] => 2024-09-23 11:46:38
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=2426
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [203] => WP_Post Object
                (
                    [ID] => 2424
                    [post_author] => 5
                    [post_date] => 2020-12-14 15:01:40
                    [post_date_gmt] => 2020-12-14 15:01:40
                    [post_content] => 
                    [post_title] => Sanofi – Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => sanofi-translate-bio-collaboration-and-license-agreement-as-amended-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 12:02:47
                    [post_modified_gmt] => 2024-09-23 12:02:47
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=2424
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [204] => WP_Post Object
                (
                    [ID] => 1309
                    [post_author] => 7
                    [post_date] => 2020-05-23 17:17:44
                    [post_date_gmt] => 2020-05-23 17:17:44
                    [post_content] => 
                    [post_title] => IMI 2 Joint Undertaking  Model Consortium Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => imi-2joint-undertaking-model-consortium-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 15:58:19
                    [post_modified_gmt] => 2024-09-19 15:58:19
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1309
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [205] => WP_Post Object
                (
                    [ID] => 1287
                    [post_author] => 6
                    [post_date] => 2020-05-22 23:05:30
                    [post_date_gmt] => 2020-05-22 23:05:30
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-07 13:56:00
                    [post_modified_gmt] => 2024-11-07 13:56:00
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1287
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [206] => WP_Post Object
                (
                    [ID] => 1285
                    [post_author] => 6
                    [post_date] => 2020-05-22 23:01:07
                    [post_date_gmt] => 2020-05-22 23:01:07
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-07 15:04:45
                    [post_modified_gmt] => 2024-11-07 15:04:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1285
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [207] => WP_Post Object
                (
                    [ID] => 1283
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:57:44
                    [post_date_gmt] => 2020-05-22 22:57:44
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:36:58
                    [post_modified_gmt] => 2024-09-23 10:36:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1283
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [208] => WP_Post Object
                (
                    [ID] => 1282
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:56:18
                    [post_date_gmt] => 2020-05-22 22:56:18
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-19 14:57:56
                    [post_modified_gmt] => 2023-06-19 14:57:56
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1282
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [209] => WP_Post Object
                (
                    [ID] => 1281
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:55:22
                    [post_date_gmt] => 2020-05-22 22:55:22
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:33:38
                    [post_modified_gmt] => 2024-09-20 07:33:38
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1281
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [210] => WP_Post Object
                (
                    [ID] => 1280
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:54:32
                    [post_date_gmt] => 2020-05-22 22:54:32
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-iia-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 10:24:28
                    [post_modified_gmt] => 2023-06-20 10:24:28
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1280
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [211] => WP_Post Object
                (
                    [ID] => 1275
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:39:41
                    [post_date_gmt] => 2020-05-22 22:39:41
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:33:11
                    [post_modified_gmt] => 2024-09-23 10:33:11
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1275
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [212] => WP_Post Object
                (
                    [ID] => 1273
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:37:54
                    [post_date_gmt] => 2020-05-22 22:37:54
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-iia-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 10:15:03
                    [post_modified_gmt] => 2023-06-20 10:15:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1273
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [213] => WP_Post Object
                (
                    [ID] => 1267
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:26:39
                    [post_date_gmt] => 2020-05-22 22:26:39
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-07 13:11:30
                    [post_modified_gmt] => 2024-11-07 13:11:30
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1267
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [214] => WP_Post Object
                (
                    [ID] => 1266
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:25:16
                    [post_date_gmt] => 2020-05-22 22:25:16
                    [post_content] => 
                    [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => imi-2-joint-undertaking-model-consortium-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 16:01:08
                    [post_modified_gmt] => 2024-09-19 16:01:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1266
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [215] => WP_Post Object
                (
                    [ID] => 1262
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:18:41
                    [post_date_gmt] => 2020-05-22 22:18:41
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:21:26
                    [post_modified_gmt] => 2024-09-20 07:21:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1262
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [216] => WP_Post Object
                (
                    [ID] => 1259
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:04:31
                    [post_date_gmt] => 2020-05-22 22:04:31
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 10:17:15
                    [post_modified_gmt] => 2023-06-20 10:17:15
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1259
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [217] => WP_Post Object
                (
                    [ID] => 1258
                    [post_author] => 6
                    [post_date] => 2020-05-22 22:03:08
                    [post_date_gmt] => 2020-05-22 22:03:08
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:32:39
                    [post_modified_gmt] => 2024-09-20 07:32:39
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1258
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [218] => WP_Post Object
                (
                    [ID] => 1248
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:36:47
                    [post_date_gmt] => 2020-05-22 21:36:47
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:42:59
                    [post_modified_gmt] => 2023-06-21 07:42:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1248
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [219] => WP_Post Object
                (
                    [ID] => 1245
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:32:14
                    [post_date_gmt] => 2020-05-22 21:32:14
                    [post_content] => 
                    [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => imi-2-joint-undertaking-model-consortium-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 15:54:36
                    [post_modified_gmt] => 2024-09-19 15:54:36
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1245
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [220] => WP_Post Object
                (
                    [ID] => 1243
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:29:10
                    [post_date_gmt] => 2020-05-22 21:29:10
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-iia-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:56:09
                    [post_modified_gmt] => 2023-06-20 09:56:09
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1243
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [221] => WP_Post Object
                (
                    [ID] => 1242
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:26:04
                    [post_date_gmt] => 2020-05-22 21:26:04
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:49:55
                    [post_modified_gmt] => 2024-09-20 07:49:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1242
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [222] => WP_Post Object
                (
                    [ID] => 1240
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:22:47
                    [post_date_gmt] => 2020-05-22 21:22:47
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:26:42
                    [post_modified_gmt] => 2024-09-23 10:26:42
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1240
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [223] => WP_Post Object
                (
                    [ID] => 1239
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:21:49
                    [post_date_gmt] => 2020-05-22 21:21:49
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:08:51
                    [post_modified_gmt] => 2024-09-20 07:08:51
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1239
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [224] => WP_Post Object
                (
                    [ID] => 1238
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:20:51
                    [post_date_gmt] => 2020-05-22 21:20:51
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement-5
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:45:19
                    [post_modified_gmt] => 2023-06-21 07:45:19
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1238
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [225] => WP_Post Object
                (
                    [ID] => 1237
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:19:08
                    [post_date_gmt] => 2020-05-22 21:19:08
                    [post_content] => 
                    [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => imi-2-joint-undertaking-model-consortium-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 15:55:21
                    [post_modified_gmt] => 2024-09-19 15:55:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1237
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [226] => WP_Post Object
                (
                    [ID] => 1235
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:01:14
                    [post_date_gmt] => 2020-05-22 21:01:14
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:52:08
                    [post_modified_gmt] => 2024-09-20 07:52:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1235
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [227] => WP_Post Object
                (
                    [ID] => 1233
                    [post_author] => 6
                    [post_date] => 2020-05-22 21:00:08
                    [post_date_gmt] => 2020-05-22 21:00:08
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:44:08
                    [post_modified_gmt] => 2023-06-21 07:44:08
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1233
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [228] => WP_Post Object
                (
                    [ID] => 1227
                    [post_author] => 6
                    [post_date] => 2020-05-22 20:48:27
                    [post_date_gmt] => 2020-05-22 20:48:27
                    [post_content] => 
                    [post_title] => WHO – Manufacturer, Ebola Products Collaboration LOA Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => ebola-who-manufacturer-loa-annex
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2022-10-13 12:56:58
                    [post_modified_gmt] => 2022-10-13 12:56:58
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1227
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [229] => WP_Post Object
                (
                    [ID] => 1226
                    [post_author] => 6
                    [post_date] => 2020-05-22 20:47:05
                    [post_date_gmt] => 2020-05-22 20:47:05
                    [post_content] => 
                    [post_title] => WHO Template Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => who-template-material-transfer-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-30 15:08:03
                    [post_modified_gmt] => 2024-10-30 15:08:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1226
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [230] => WP_Post Object
                (
                    [ID] => 1220
                    [post_author] => 6
                    [post_date] => 2020-05-22 20:05:59
                    [post_date_gmt] => 2020-05-22 20:05:59
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-28 12:59:18
                    [post_modified_gmt] => 2024-10-28 12:59:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1220
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [231] => WP_Post Object
                (
                    [ID] => 1214
                    [post_author] => 6
                    [post_date] => 2020-05-22 19:55:41
                    [post_date_gmt] => 2020-05-22 19:55:41
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:16:49
                    [post_modified_gmt] => 2024-09-20 07:16:49
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1214
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [232] => WP_Post Object
                (
                    [ID] => 1190
                    [post_author] => 6
                    [post_date] => 2020-05-22 01:59:48
                    [post_date_gmt] => 2020-05-22 01:59:48
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:24:04
                    [post_modified_gmt] => 2024-09-23 10:24:04
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1190
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [233] => WP_Post Object
                (
                    [ID] => 1185
                    [post_author] => 6
                    [post_date] => 2020-05-22 00:10:01
                    [post_date_gmt] => 2020-05-22 00:10:01
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2021-08-20 12:45:45
                    [post_modified_gmt] => 2021-08-20 12:45:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1185
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [234] => WP_Post Object
                (
                    [ID] => 1182
                    [post_author] => 6
                    [post_date] => 2020-05-22 00:02:42
                    [post_date_gmt] => 2020-05-22 00:02:42
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-iia-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 09:58:52
                    [post_modified_gmt] => 2023-06-20 09:58:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1182
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [235] => WP_Post Object
                (
                    [ID] => 1177
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:53:56
                    [post_date_gmt] => 2020-05-21 23:53:56
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:18:46
                    [post_modified_gmt] => 2024-09-20 07:18:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1177
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [236] => WP_Post Object
                (
                    [ID] => 1176
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:52:12
                    [post_date_gmt] => 2020-05-21 23:52:12
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-17 10:30:44
                    [post_modified_gmt] => 2023-10-17 10:30:44
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1176
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [237] => WP_Post Object
                (
                    [ID] => 1166
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:26:07
                    [post_date_gmt] => 2020-05-21 23:26:07
                    [post_content] => 
                    [post_title] => IMI 2 Joint Undertaking Model Consortium Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => imi-2-joint-undertaking-model-consortium-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 15:59:37
                    [post_modified_gmt] => 2024-09-19 15:59:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1166
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [238] => WP_Post Object
                (
                    [ID] => 1164
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:22:37
                    [post_date_gmt] => 2020-05-21 23:22:37
                    [post_content] => 
                    [post_title] => AUTM Model Inter-Institutional Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => autm-model-iia
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 10:10:29
                    [post_modified_gmt] => 2023-06-20 10:10:29
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1164
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [239] => WP_Post Object
                (
                    [ID] => 1160
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:18:03
                    [post_date_gmt] => 2020-05-21 23:18:03
                    [post_content] => 
                    [post_title] => PATH - Aridis, Rotavirus Vaccine Development Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => aridis-path-vaccine-formulation-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 10:32:40
                    [post_modified_gmt] => 2024-09-23 10:32:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1160
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [240] => WP_Post Object
                (
                    [ID] => 1155
                    [post_author] => 6
                    [post_date] => 2020-05-21 23:09:39
                    [post_date_gmt] => 2020-05-21 23:09:39
                    [post_content] => 
                    [post_title] => WHO Template Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => template-collaboration-agreement-with-who
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-30 15:08:39
                    [post_modified_gmt] => 2024-10-30 15:08:39
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1155
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [241] => WP_Post Object
                (
                    [ID] => 1150
                    [post_author] => 6
                    [post_date] => 2020-05-21 22:53:25
                    [post_date_gmt] => 2020-05-21 22:53:25
                    [post_content] => 
                    [post_title] => Academic Institution - Company, Research Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => redacted-collaboration-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 07:47:20
                    [post_modified_gmt] => 2023-06-21 07:47:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1150
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [242] => WP_Post Object
                (
                    [ID] => 1140
                    [post_author] => 6
                    [post_date] => 2020-05-21 22:37:27
                    [post_date_gmt] => 2020-05-21 22:37:27
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 08:06:11
                    [post_modified_gmt] => 2024-09-20 08:06:11
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1140
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [243] => WP_Post Object
                (
                    [ID] => 1112
                    [post_author] => 6
                    [post_date] => 2020-05-21 21:06:05
                    [post_date_gmt] => 2020-05-21 21:06:05
                    [post_content] => 
                    [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => license-and-collaboration-agreement-between-merck-and-bioprotection-systems-corp-wholly-owned-subsidiary-of-newlink-genetic-corporation
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-07 13:05:43
                    [post_modified_gmt] => 2024-11-07 13:05:43
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1112
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [244] => WP_Post Object
                (
                    [ID] => 1107
                    [post_author] => 6
                    [post_date] => 2020-05-21 20:57:25
                    [post_date_gmt] => 2020-05-21 20:57:25
                    [post_content] => 
                    [post_title] => Lambert Toolkit, Consortium Agreement D Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => lambert-agreement-d
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 07:20:02
                    [post_modified_gmt] => 2024-09-20 07:20:02
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=provision_document&p=1107
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [invalid_get] => 
    [is_text_search] => 
    [has_agreement_filters] => 1
    [has_any_agreement_filter] => Array
        (
            [agreement-type] => 
        )

    [found_agreements] => 1
    [has_provision_filters] => 
    [found_provisions] => 1
    [lbl_quick_search:GHIAA2019\MapguideSearch:private] => Search results for:
    [lbl_issue:GHIAA2019\MapguideSearch:private] => Issue:
    [lbl_key_term:GHIAA2019\MapguideSearch:private] => Key Term:
    [lbl_agreement_type:GHIAA2019\MapguideSearch:private] => Agreement Type:
    [lbl_partner_type:GHIAA2019\MapguideSearch:private] => Partner Type:
    [lbl_technology:GHIAA2019\MapguideSearch:private] => Technology:
    [lbl_development_stage:GHIAA2019\MapguideSearch:private] => Development Stage:
    [issues_by_id:GHIAA2019\MapguideSearch:private] => Array
        (
            [101] => WP_Term Object
                (
                    [term_id] => 101
                    [name] => Access plans & principles
                    [slug] => equitable-access
                    [term_group] => 0
                    [term_taxonomy_id] => 101
                    [taxonomy] => issue
                    [description] => 
 	How should equitable or global access be defined?
 	Should the developer be required to comply with an equitable access policy?
 	Should the developer be required to establish an access plan?

                    [parent] => 46
                    [count] => 51
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [100] => WP_Term Object
                (
                    [term_id] => 100
                    [name] => Affordable pricing
                    [slug] => pricing
                    [term_group] => 0
                    [term_taxonomy_id] => 100
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 49
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [66] => WP_Term Object
                (
                    [term_id] => 66
                    [name] => Benefit sharing
                    [slug] => benefit-revenue-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 66
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 15
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [53] => WP_Term Object
                (
                    [term_id] => 53
                    [name] => Business model
                    [slug] => business-model
                    [term_group] => 0
                    [term_taxonomy_id] => 53
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [371] => WP_Term Object
                (
                    [term_id] => 371
                    [name] => Clinical trial conduct
                    [slug] => clinical-trial-conduct
                    [term_group] => 0
                    [term_taxonomy_id] => 371
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 15
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [84] => WP_Term Object
                (
                    [term_id] => 84
                    [name] => Confidentiality
                    [slug] => confidentiality
                    [term_group] => 0
                    [term_taxonomy_id] => 84
                    [taxonomy] => issue
                    [description] => 
 	What is the scope of confidential information?
 	What are the obligations of the parties to protect confidential information?
 	Are there any exceptions to the confidentiality obligations?
 	Are the parties permitted to make public announcements related to the project?
 	Can the parties use each other’s name and logo for general marketing materials?

                    [parent] => 49
                    [count] => 102
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [271] => WP_Term Object
                (
                    [term_id] => 271
                    [name] => Donation
                    [slug] => donation
                    [term_group] => 0
                    [term_taxonomy_id] => 271
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 5
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [72] => WP_Term Object
                (
                    [term_id] => 72
                    [name] => Effects of termination
                    [slug] => effect-of-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 72
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 84
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [281] => WP_Term Object
                (
                    [term_id] => 281
                    [name] => Ensuring continuity
                    [slug] => ensuring-continuity
                    [term_group] => 0
                    [term_taxonomy_id] => 281
                    [taxonomy] => issue
                    [description] => 
 	Under what circumstances can the continuity rights be exercised? (What are the conditions precedent?)
 	What is an appropriate scope for the continuity rights? What are the rights and obligations of each party?
 	Should related license grants vest upon execution of the agreement, or at a later stage in development?
 	Should there be an escrow requirement?
 	Should there be any restrictions on the developer’s ability to transfer project-related intellectual property to a third party?

                    [parent] => 46
                    [count] => 55
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [46] => WP_Term Object
                (
                    [term_id] => 46
                    [name] => Equitable access
                    [slug] => access-to-medicines
                    [term_group] => 0
                    [term_taxonomy_id] => 46
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [278] => WP_Term Object
                (
                    [term_id] => 278
                    [name] => Governance
                    [slug] => roles-responsibilities
                    [term_group] => 0
                    [term_taxonomy_id] => 278
                    [taxonomy] => issue
                    [description] => 
 	Do the parties govern the project through a joint steering committee ("JSC")? If so, what are the parties expressly designated roles and responsibilities with respect to the JSC?
 	Are there other committees, important governance bodies, or designated individual positions? What are the parties' roles and responsibilities with respect to them?
 	Are the parties required to meet in accordance with a defined schedule for decision-making and progress reporting activities?
 	What are the resolution mechanisms for disputes related to the agreement?
 	Are there any requirements for policies or procedures to manage potential conflicts of interest?

                    [parent] => 53
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [80] => WP_Term Object
                (
                    [term_id] => 80
                    [name] => Indemnification & liability
                    [slug] => indemnity
                    [term_group] => 0
                    [term_taxonomy_id] => 80
                    [taxonomy] => issue
                    [description] => 
 	What occurrences could result in a liability claim against which one party will indemnify the other?
 	Are there any circumstances under which one party will not indemnify the other?
 	What is the process for managing liability claims?
 	Are there government or other types of indemnification schemes?
 	Is there any limitation or monetary cap on each party’s liabilities under the agreement?

                    [parent] => 50
                    [count] => 99
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [257] => WP_Term Object
                (
                    [term_id] => 257
                    [name] => Information sharing
                    [slug] => information-sharing-information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 257
                    [taxonomy] => issue
                    [description] => 
 	What financial and project progress information must be shared between the parties?
 	What is the required timeline for sharing information?
 	How is the receiving party permitted to use the information received?
 	Do the parties have the right to verify the information reported?

                    [parent] => 49
                    [count] => 92
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [109] => WP_Term Object
                (
                    [term_id] => 109
                    [name] => Insurance
                    [slug] => insurance
                    [term_group] => 0
                    [term_taxonomy_id] => 109
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 50
                    [count] => 62
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [48] => WP_Term Object
                (
                    [term_id] => 48
                    [name] => Intellectual property
                    [slug] => ip-ownership
                    [term_group] => 0
                    [term_taxonomy_id] => 48
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [50] => WP_Term Object
                (
                    [term_id] => 50
                    [name] => Liability
                    [slug] => liability
                    [term_group] => 0
                    [term_taxonomy_id] => 50
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [88] => WP_Term Object
                (
                    [term_id] => 88
                    [name] => License grants
                    [slug] => license-grants
                    [term_group] => 0
                    [term_taxonomy_id] => 88
                    [taxonomy] => issue
                    [description] => 
 	Are any licenses granted for the use of background or foreground intellectual property?
 	What is the scope of the licensed intellectual property?
 	What is the territory of the license?
 	Is the license exclusive or non-exclusive?
 	Are there any restrictions on the use of the licensed intellectual property?
 	Are there any specific obligations to exploit the licensed intellectual property?
 	Can the licensee grant sublicenses to third parties?
 	Will products manufactured under license be marketed as branded or generic? (i.e. will they bear the licensor’s trademarks/trade dress)

                    [parent] => 48
                    [count] => 96
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [87] => WP_Term Object
                (
                    [term_id] => 87
                    [name] => Ownership of IP
                    [slug] => ownership-ip
                    [term_group] => 0
                    [term_taxonomy_id] => 87
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 71
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [70] => WP_Term Object
                (
                    [term_id] => 70
                    [name] => Payment structures
                    [slug] => royalties-and-payments
                    [term_group] => 0
                    [term_taxonomy_id] => 70
                    [taxonomy] => issue
                    [description] => What is the payment structure under this agreement? 
What are the mechanisms to limit exposure to additional payments or expenses?
                    [parent] => 53
                    [count] => 79
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [102] => WP_Term Object
                (
                    [term_id] => 102
                    [name] => Preparedness & response
                    [slug] => outbreak-preparedness
                    [term_group] => 0
                    [term_taxonomy_id] => 102
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 13
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [268] => WP_Term Object
                (
                    [term_id] => 268
                    [name] => Product supply
                    [slug] => supply-purchase-of-products
                    [term_group] => 0
                    [term_taxonomy_id] => 268
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 43
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [49] => WP_Term Object
                (
                    [term_id] => 49
                    [name] => Protecting & sharing information
                    [slug] => information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 49
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [90] => WP_Term Object
                (
                    [term_id] => 90
                    [name] => Protection of IP
                    [slug] => protection-results
                    [term_group] => 0
                    [term_taxonomy_id] => 90
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 70
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [290] => WP_Term Object
                (
                    [term_id] => 290
                    [name] => Publication of results
                    [slug] => publication-of-results
                    [term_group] => 0
                    [term_taxonomy_id] => 290
                    [taxonomy] => issue
                    [description] => What information are the parties required or permitted to publish?
What is the required timeline for making data available?
What are the acceptable publication channels?
Is compliance with a specific open access policy required?
                    [parent] => 49
                    [count] => 61
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [372] => WP_Term Object
                (
                    [term_id] => 372
                    [name] => Quality management
                    [slug] => quality-management
                    [term_group] => 0
                    [term_taxonomy_id] => 372
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 36
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [56] => WP_Term Object
                (
                    [term_id] => 56
                    [name] => Regulatory strategy
                    [slug] => regulatory-strategy
                    [term_group] => 0
                    [term_taxonomy_id] => 56
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 53
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [81] => WP_Term Object
                (
                    [term_id] => 81
                    [name] => Representations & warranties
                    [slug] => warranties
                    [term_group] => 0
                    [term_taxonomy_id] => 81
                    [taxonomy] => issue
                    [description] => Should the parties make any warranties, and if so, what is the scope?
                    [parent] => 50
                    [count] => 88
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [86] => WP_Term Object
                (
                    [term_id] => 86
                    [name] => Technology transfer
                    [slug] => technology-transfer
                    [term_group] => 0
                    [term_taxonomy_id] => 86
                    [taxonomy] => issue
                    [description] => What is included in the technology and/or materials to be transferred?
What are the responsibilities of each party to in relation to the transfer of materials and/or technology?
                    [parent] => 49
                    [count] => 41
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [52] => WP_Term Object
                (
                    [term_id] => 52
                    [name] => Term & termination
                    [slug] => term-and-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 52
                    [taxonomy] => issue
                    [description] => Term

 	What is the term of the agreement? Is it tied to the timeline of the project or license grants?

Termination

 	Under what circumstances may a party terminate or withdraw from the agreement?

Effects of Termination

 	What are the effects of termination or withdrawal by a party?

                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [76] => WP_Term Object
                (
                    [term_id] => 76
                    [name] => Term of agreement
                    [slug] => term-of-agreement
                    [term_group] => 0
                    [term_taxonomy_id] => 76
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [74] => WP_Term Object
                (
                    [term_id] => 74
                    [name] => Termination & withdrawal
                    [slug] => termination-and-withdrawal
                    [term_group] => 0
                    [term_taxonomy_id] => 74
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 91
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [282] => WP_Term Object
                (
                    [term_id] => 282
                    [name] => Territory access commitments
                    [slug] => territory-access-commitments
                    [term_group] => 0
                    [term_taxonomy_id] => 282
                    [taxonomy] => issue
                    [description] => 
 	How should ‘territory’ be defined under the agreement? Should the definition make a distinction between different types of purchaser (e.g. public sector vs. private sector)?
 	Should the developer be required to apply for regulatory approval in priority access markets?
 	Should the developer be required to commit a proportion of the product manufactured to a certain country or purchasing organization?
 	Should the developer be required to identify a third party that could fulfill supply requirements for the access territories in the event that the developer does not?
 	Should the agreement include any anti-diversion provisions?

                    [parent] => 46
                    [count] => 58
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

        )

    [issues_by_slug:GHIAA2019\MapguideSearch:private] => Array
        (
            [equitable-access] => WP_Term Object
                (
                    [term_id] => 101
                    [name] => Access plans & principles
                    [slug] => equitable-access
                    [term_group] => 0
                    [term_taxonomy_id] => 101
                    [taxonomy] => issue
                    [description] => 
 	How should equitable or global access be defined?
 	Should the developer be required to comply with an equitable access policy?
 	Should the developer be required to establish an access plan?

                    [parent] => 46
                    [count] => 51
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [pricing] => WP_Term Object
                (
                    [term_id] => 100
                    [name] => Affordable pricing
                    [slug] => pricing
                    [term_group] => 0
                    [term_taxonomy_id] => 100
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 49
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [benefit-revenue-sharing] => WP_Term Object
                (
                    [term_id] => 66
                    [name] => Benefit sharing
                    [slug] => benefit-revenue-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 66
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 15
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [business-model] => WP_Term Object
                (
                    [term_id] => 53
                    [name] => Business model
                    [slug] => business-model
                    [term_group] => 0
                    [term_taxonomy_id] => 53
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [clinical-trial-conduct] => WP_Term Object
                (
                    [term_id] => 371
                    [name] => Clinical trial conduct
                    [slug] => clinical-trial-conduct
                    [term_group] => 0
                    [term_taxonomy_id] => 371
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 15
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [confidentiality] => WP_Term Object
                (
                    [term_id] => 84
                    [name] => Confidentiality
                    [slug] => confidentiality
                    [term_group] => 0
                    [term_taxonomy_id] => 84
                    [taxonomy] => issue
                    [description] => 
 	What is the scope of confidential information?
 	What are the obligations of the parties to protect confidential information?
 	Are there any exceptions to the confidentiality obligations?
 	Are the parties permitted to make public announcements related to the project?
 	Can the parties use each other’s name and logo for general marketing materials?

                    [parent] => 49
                    [count] => 102
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [donation] => WP_Term Object
                (
                    [term_id] => 271
                    [name] => Donation
                    [slug] => donation
                    [term_group] => 0
                    [term_taxonomy_id] => 271
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 5
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [effect-of-termination] => WP_Term Object
                (
                    [term_id] => 72
                    [name] => Effects of termination
                    [slug] => effect-of-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 72
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 84
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [ensuring-continuity] => WP_Term Object
                (
                    [term_id] => 281
                    [name] => Ensuring continuity
                    [slug] => ensuring-continuity
                    [term_group] => 0
                    [term_taxonomy_id] => 281
                    [taxonomy] => issue
                    [description] => 
 	Under what circumstances can the continuity rights be exercised? (What are the conditions precedent?)
 	What is an appropriate scope for the continuity rights? What are the rights and obligations of each party?
 	Should related license grants vest upon execution of the agreement, or at a later stage in development?
 	Should there be an escrow requirement?
 	Should there be any restrictions on the developer’s ability to transfer project-related intellectual property to a third party?

                    [parent] => 46
                    [count] => 55
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [access-to-medicines] => WP_Term Object
                (
                    [term_id] => 46
                    [name] => Equitable access
                    [slug] => access-to-medicines
                    [term_group] => 0
                    [term_taxonomy_id] => 46
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [roles-responsibilities] => WP_Term Object
                (
                    [term_id] => 278
                    [name] => Governance
                    [slug] => roles-responsibilities
                    [term_group] => 0
                    [term_taxonomy_id] => 278
                    [taxonomy] => issue
                    [description] => 
 	Do the parties govern the project through a joint steering committee ("JSC")? If so, what are the parties expressly designated roles and responsibilities with respect to the JSC?
 	Are there other committees, important governance bodies, or designated individual positions? What are the parties' roles and responsibilities with respect to them?
 	Are the parties required to meet in accordance with a defined schedule for decision-making and progress reporting activities?
 	What are the resolution mechanisms for disputes related to the agreement?
 	Are there any requirements for policies or procedures to manage potential conflicts of interest?

                    [parent] => 53
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [indemnity] => WP_Term Object
                (
                    [term_id] => 80
                    [name] => Indemnification & liability
                    [slug] => indemnity
                    [term_group] => 0
                    [term_taxonomy_id] => 80
                    [taxonomy] => issue
                    [description] => 
 	What occurrences could result in a liability claim against which one party will indemnify the other?
 	Are there any circumstances under which one party will not indemnify the other?
 	What is the process for managing liability claims?
 	Are there government or other types of indemnification schemes?
 	Is there any limitation or monetary cap on each party’s liabilities under the agreement?

                    [parent] => 50
                    [count] => 99
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [information-sharing-information-sharing] => WP_Term Object
                (
                    [term_id] => 257
                    [name] => Information sharing
                    [slug] => information-sharing-information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 257
                    [taxonomy] => issue
                    [description] => 
 	What financial and project progress information must be shared between the parties?
 	What is the required timeline for sharing information?
 	How is the receiving party permitted to use the information received?
 	Do the parties have the right to verify the information reported?

                    [parent] => 49
                    [count] => 92
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [insurance] => WP_Term Object
                (
                    [term_id] => 109
                    [name] => Insurance
                    [slug] => insurance
                    [term_group] => 0
                    [term_taxonomy_id] => 109
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 50
                    [count] => 62
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [ip-ownership] => WP_Term Object
                (
                    [term_id] => 48
                    [name] => Intellectual property
                    [slug] => ip-ownership
                    [term_group] => 0
                    [term_taxonomy_id] => 48
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [liability] => WP_Term Object
                (
                    [term_id] => 50
                    [name] => Liability
                    [slug] => liability
                    [term_group] => 0
                    [term_taxonomy_id] => 50
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [license-grants] => WP_Term Object
                (
                    [term_id] => 88
                    [name] => License grants
                    [slug] => license-grants
                    [term_group] => 0
                    [term_taxonomy_id] => 88
                    [taxonomy] => issue
                    [description] => 
 	Are any licenses granted for the use of background or foreground intellectual property?
 	What is the scope of the licensed intellectual property?
 	What is the territory of the license?
 	Is the license exclusive or non-exclusive?
 	Are there any restrictions on the use of the licensed intellectual property?
 	Are there any specific obligations to exploit the licensed intellectual property?
 	Can the licensee grant sublicenses to third parties?
 	Will products manufactured under license be marketed as branded or generic? (i.e. will they bear the licensor’s trademarks/trade dress)

                    [parent] => 48
                    [count] => 96
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [ownership-ip] => WP_Term Object
                (
                    [term_id] => 87
                    [name] => Ownership of IP
                    [slug] => ownership-ip
                    [term_group] => 0
                    [term_taxonomy_id] => 87
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 71
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [royalties-and-payments] => WP_Term Object
                (
                    [term_id] => 70
                    [name] => Payment structures
                    [slug] => royalties-and-payments
                    [term_group] => 0
                    [term_taxonomy_id] => 70
                    [taxonomy] => issue
                    [description] => What is the payment structure under this agreement? 
What are the mechanisms to limit exposure to additional payments or expenses?
                    [parent] => 53
                    [count] => 79
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [outbreak-preparedness] => WP_Term Object
                (
                    [term_id] => 102
                    [name] => Preparedness & response
                    [slug] => outbreak-preparedness
                    [term_group] => 0
                    [term_taxonomy_id] => 102
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 13
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [supply-purchase-of-products] => WP_Term Object
                (
                    [term_id] => 268
                    [name] => Product supply
                    [slug] => supply-purchase-of-products
                    [term_group] => 0
                    [term_taxonomy_id] => 268
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 43
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [information-sharing] => WP_Term Object
                (
                    [term_id] => 49
                    [name] => Protecting & sharing information
                    [slug] => information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 49
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [protection-results] => WP_Term Object
                (
                    [term_id] => 90
                    [name] => Protection of IP
                    [slug] => protection-results
                    [term_group] => 0
                    [term_taxonomy_id] => 90
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 70
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [publication-of-results] => WP_Term Object
                (
                    [term_id] => 290
                    [name] => Publication of results
                    [slug] => publication-of-results
                    [term_group] => 0
                    [term_taxonomy_id] => 290
                    [taxonomy] => issue
                    [description] => What information are the parties required or permitted to publish?
What is the required timeline for making data available?
What are the acceptable publication channels?
Is compliance with a specific open access policy required?
                    [parent] => 49
                    [count] => 61
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [quality-management] => WP_Term Object
                (
                    [term_id] => 372
                    [name] => Quality management
                    [slug] => quality-management
                    [term_group] => 0
                    [term_taxonomy_id] => 372
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 36
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [regulatory-strategy] => WP_Term Object
                (
                    [term_id] => 56
                    [name] => Regulatory strategy
                    [slug] => regulatory-strategy
                    [term_group] => 0
                    [term_taxonomy_id] => 56
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 53
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [warranties] => WP_Term Object
                (
                    [term_id] => 81
                    [name] => Representations & warranties
                    [slug] => warranties
                    [term_group] => 0
                    [term_taxonomy_id] => 81
                    [taxonomy] => issue
                    [description] => Should the parties make any warranties, and if so, what is the scope?
                    [parent] => 50
                    [count] => 88
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [technology-transfer] => WP_Term Object
                (
                    [term_id] => 86
                    [name] => Technology transfer
                    [slug] => technology-transfer
                    [term_group] => 0
                    [term_taxonomy_id] => 86
                    [taxonomy] => issue
                    [description] => What is included in the technology and/or materials to be transferred?
What are the responsibilities of each party to in relation to the transfer of materials and/or technology?
                    [parent] => 49
                    [count] => 41
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [term-and-termination] => WP_Term Object
                (
                    [term_id] => 52
                    [name] => Term & termination
                    [slug] => term-and-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 52
                    [taxonomy] => issue
                    [description] => Term

 	What is the term of the agreement? Is it tied to the timeline of the project or license grants?

Termination

 	Under what circumstances may a party terminate or withdraw from the agreement?

Effects of Termination

 	What are the effects of termination or withdrawal by a party?

                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [term-of-agreement] => WP_Term Object
                (
                    [term_id] => 76
                    [name] => Term of agreement
                    [slug] => term-of-agreement
                    [term_group] => 0
                    [term_taxonomy_id] => 76
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [termination-and-withdrawal] => WP_Term Object
                (
                    [term_id] => 74
                    [name] => Termination & withdrawal
                    [slug] => termination-and-withdrawal
                    [term_group] => 0
                    [term_taxonomy_id] => 74
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 91
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [territory-access-commitments] => WP_Term Object
                (
                    [term_id] => 282
                    [name] => Territory access commitments
                    [slug] => territory-access-commitments
                    [term_group] => 0
                    [term_taxonomy_id] => 282
                    [taxonomy] => issue
                    [description] => 
 	How should ‘territory’ be defined under the agreement? Should the definition make a distinction between different types of purchaser (e.g. public sector vs. private sector)?
 	Should the developer be required to apply for regulatory approval in priority access markets?
 	Should the developer be required to commit a proportion of the product manufactured to a certain country or purchasing organization?
 	Should the developer be required to identify a third party that could fulfill supply requirements for the access territories in the event that the developer does not?
 	Should the agreement include any anti-diversion provisions?

                    [parent] => 46
                    [count] => 58
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

        )

    [filter_issues:GHIAA2019\MapguideSearch:private] => Array
        (
        )

)